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ABSTRACT
The fusion protein of the Newcastle Disease Virus (NDV) contains three
hydrophobic domains. To explore the topogenic signals of these domains
mutants were constructed in which each of the hydrophobic domains was
deleted. The membrane insertion and topology of these proteins was
characterized in a wheat germ cell-free translation system supplemented with
canine microsomal membranes. The results indicated that the first 13 amino
acids of the fusion protein are necessary to confer translation inhibition by SRP.
Translocation of the nascent chains containing all or part of the first hydrophobic
sequence resulted in the appearance of a species of higher molecular weight
consistent with glycosylation of at least four of the five potential N-linked
glyco ylation sites. When glycosylation was inhibited with a glycosylation
competitor peptide , signal sequence cleavage was detected. Protease digestion
of mutants missing the C-terminal hydrophobic domain indicated that the C-
terminus has stop transfer activity. A comparison of membrane insertion of the
wild-type fusion protein to that of a mutant missing the second hydrophobic
domain , the fusion sequence , indicated that the fusion domain has stop-transfer
activity when synthesized in vitro. Furthermore , the fusion domain shows little
signal sequence activity when positioned near the amino terminus of the fusion
protein.
The fusion protein has a highly conserved leucine zipper motif immediately
upstream from the transmembrane domain of the F1 subunit. In order to determine
the role that the conserved leucines have for the oligomeric structure and biological
activity of the NDV fusion protein , the heptadic leucines at positions 481 488 , and
495 were changed individually and in combination to an alanine residue. Whereas
single amino acid changes had little effect on fusion , substitution of two or three
leucine residues abolished the fusogenic activity of the protein although cell surface
expression of the mutants and sedimentation in sucrose gradients was similar to that
of the wild type. Furthermore , deletion of the C-terminal 91 amino acids, including
the leucine zipper motif and transmembrane domain resulted in secretion of an
oligomeric structure. These results indicate that the conserved leucines do not play
a role in oligomer formation but are required for the fusogenic abilty of the protein.
When the polar face of the potential alpha helix was altered by nonconservative
substitutions of a serine-to-alanine (position 473), glutamic acid-to- Iysine (position
482) or an asparagine-to- Iysine (position 485), the fusogenic abilty of the protein
was not significantly disrupted.
A phenylalanine residue is at the amino terminus of the F1 protein of all
paramyxovirus fusion proteins with the exception of the avirulent strains which
have a leucine residue in this position. To explore the role of this phenylalanine
in the fusion activity of the protein , this residue was changed to leucine (F117L)
or to glycine (F117G) by site-specific mutagenesis while maintaining the
cleavage site sequence of virulent strains of NDV. Whereas both the wild-type
and the F117G proteins were proteolytically cleaved and F 1 was detected, the
leucine subsitution abolished cleavage. When co-expressed with the HN protein
the fusion protein with either a phenylalanine and glycine residue at position 117
but not a leucine , was shown to stimulate membrane fusion. However
incubation in trypsin activated the fusion activity of the F117L protein. Thus the
presence of a leucine at position 117 of the precursor sequence blocks cleavage
but not fusion acitivity, and indicated that the phenylalanine at the amino terminus
of the F 1 subunit is not conserved for the fusion activity of the protein.
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CHAPTER I
INTRODUCTION
Newcastle disease was initially recorded near Batavia , Java, in Indonesia
prior to 1926, where it caused a fatal respiratory and nervous system disease.
The virus was next detected on a poultry farm near Newcastle-on- Tyne , England
and then spread throughout the continent (reviewed in Shope , 1964). When the
disease erupted, none of the infected birds survived and the disease would often
temporarily disappear. In 1936 the same virus mysteriously appeared in the
United States. The disease was much milder than had occurred in other
countries and was not identified for many years. Whereas the original strains
were very virulent with a mortality rate near 100%, the American version had
attenuated virulence. During this time, poultry production was increasing in
importance and economic pressures led to the study of the virus (Brandly, 1964).
The virus has now been noted in virtually every country in the world
possibly due to the wide variety of reservoir hosts (Roberston , 1964). The virus
can infect virtually all of the 8 000 species of wild and domestic birds , making it a
very important pathogen (Kaleta, 1988). The strain of Newcastle disease virus
(NDV) most frequently identified throughout this country is the B1 isolate. Due to
ease in disseminating a live virus , this avirulent strain is used to vaccinate poultry
flocks against virulent isolates. This continuing practice perpetuates the viral
infection and may also allow for the possible emergence of more pathogenic
isolates from the avirulent vaccine strains (Hitchner, 1964).
NDV is a member of the Paramyxoviridae family. This family of viruses is
structurally similar to orthomyxovirus and rhabdovirus families. All have a
negative strand RNA genome protected by a helical nucleocapsid and a lipid
bilayer membrane. The single strand genome of the paramyxoviruses and
rhabdoviruses is nonsegmented whereas that of the orthomyxoviruses is
segmented.
The Paramyxoviridae family is divided up into three genera based on the
possession of hemagglutination and neuraminidase activities (described in
Kingsbury, 1990). Members of the Morbillvirus genus lacks neuraminidase
activity and include the measles and canine distemper viruses. Members of the
Pneumovirus geunus lack both neuraminidase and hemagglutination activities
and include the respiratory syncytial virus. Members of the Paramyxovirus genus
possess both neuraminidase and hemagglutination activities and include Sendai
human parainfluenza , mumps , SV5 and Newcastle disease viruses.
The envelope of the NDV virion is studded with spike structures made up
of the hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins. The
hemagglutinin activity of the HN protein is believed to mediate attachment of the
virion to the target cell (reviewed in Morrison and Portner, 1991). The protein
binds to cellular sialic acid-containing receptors and can cause agglutination of
eryhrocytes. The neuraminidase activity allows the virion to cleave sialic acid.
This activity presumably prevents the virions from aggregating with sialic acid-
containing glycoproteins on neighboring virions. The other spike protein
, F
mediates fusion of the viral membrane with that of the target cell membrane and
fusion of an infected cell with an adjacent cell (Bratt and Gallagher
, 1969)
After the virion attaches to its target cell , the nucleocapsid must enter the
cell for replication to occur. This crucial step involves fusion of the viral
membrane with the membrane of the target cell and release of the nucleocapsid
directly into the cytoplasm (Kingsbury, 1990). This fusion reaction is mediated by
the virion surface proteins and occurs at a neutral pH at the plasma membrane
(reviewed in White, 1990, and Kielian and Jungerwirth , 1990). Whereas HN is
required for fusion , the F protein is thought to directly mediate the membrane
fusion event (Scheid and Choppin , 1974). Once the nucleocapsid is inside the
cytoplasm, it uses the biosynthetic machinery of the cell to begin generation of
new virus particles (reviewed in Peeples, 1988). The NDV genome is replicated
in the cytoplasm and serves as a template for synthesis of the viral mRNAs.
dro hobic domains. The amino acid sequence of a protein encodes all
of the information required for proper folding and post-translational modifications
necessary for biological activity. For membrane proteins , determinants within the
sequence direct membrane targeting and integration and are often hydrophobic
segments within the protein (reviewed in Lingappa, 1989, and von Heijne 1988).
The amino acid sequence of the two NDV spike proteins predicted hydrophobic
segments near the amino-termini of both proteins. The single hydrophobic
domain of the HN protein is located near the amino terminus. The F protein
contains three hydrophobic domains. One domain is located near the amino
terminus , another near the carboxy terminus, typical of type I integral membrane
proteins , and a third hydrophobic domain is located at an internal position within
the nascent protein.
The amino-terminal hydrophobic segment of integral membrane proteins is
often a signal sequence. The function of this signal has been analyzed in cell-
free systems that reproduce the steps required for translocation of nascent
proteins across the ER membrane (Erickson and Blobel , 1983). These signals
are recognized cotranslationally by a protein-RNA complex termed the signal
recognition particle (SRP; Walter and Blobel
, 1981 a, reviewed in Walter and
Lingappa, 1986 , and Rapoport, 1992). This interaction has been shown to arrest
translation in a wheat germ cell-free system (Walter and Blobel, 1981 c). The
SRP-signal complex directs the ribosome to a SRP receptor in the ER membrane
(Gilmore et ai , 1982; Walter and Blobel , 1981b). SRP is released in a GTP-
dependent manner, protein synthesis resumes , and the growing polypeptide is
translocated across the ER membrane (Connolly and Gilmore , 1989; Walter and
Blobel, 1981 c). Protein domains on the luminal side of the ER are eventually
exposed on the outside of the cell. The ultimate orientation of the protein in the
plasma membrane is determined by the method of insertion into the ER
membrane.
According to the loop model , amino terminal signal sequences are
inserted into the ER membrane as a hairpin loop with the N-terminus of the signal
remaining on the cytoplasmic side (Engelman and Steitz, 1981). The final
topology of the protein is determined by the presence or absence of a cleavage
site. Cleavage of the signal (also known as leader peptide) allows release of the
terminus from the membrane. Proof for this loop model was provided by Shaw
and coworkers who have shown that mutations of the VSV G protein cleavage
site resulted in a protein that was anchored by the signal sequence (1988). 
additional mutant with an extension of the amino-terminus indicated that the
extreme amino-terminal residues were cytoplasmically exposed.
Cleavable signal sequences display a remarkable lack of primary
sequence homology. A comparison of many signal sequences revealed no
regions of strict homology, outside of the cleavage site (von Heijne
, 1983).
However, several characteristics have been identified. They usually have a
tendency to take up an alpha-helical structure in nonpolar environments
(Gierasch , 1989). Von Heijne (1983 , 1985) has shown that the signal consists of
three regions. The amino terminus is variable in length and composition but
carries a net positive charge. The internal region of the signal is approximately
.,.
10 residues in length and is very hydrophobic. The third region is immediately
upstream from the cleavage site, and usually five to seven mainly polar residues
comprise this C-terminal side of the signal.
Noncleavable signal sequences are functionally similar to cleavable
signals but, due to the absence of a cleavage site, the segment also serves to
anchor the protein in the membrane (Spiess and Lodish , 1986; Wickner and
Lodish, 1985). The hydrophobic nature of a type II signal , and amino terminal
location, are often sufficient for both membrane targeting and anchoring functions
(Zerial et aI., 1987). However, the residues adjacent to this segment are likely to
influence the membrane orientation. Wilson and coworkers have shown that
removal of 28 residues upstream of the type II signal in the NDV HN protein did
not abolish recognition by SRP but resulted in reversal of the membrane
orientation of the protein (Wilson et ai , 1987). Also, an analysis of the sequences
of known transmembrane proteins led to the proposal of the "positive inside rule
in which the most positively charged end of the protein is retained in the
cytoplasm (von Heijne , 1986).
For integral membrane proteins, translocation is terminated when a
hydrophobic stop-transfer sequence, often located near the C-terminus , enters
the translocation site (Yost et ai , 1983). The mechanism by which translocation is
terminated by these segments is unknown. Twenty-two amino acids are
required to span a bilayer as an alpha-helix , and membrane-spanning segments
are on average 24 residues long (Gierasch , 1989; Lodish , 1988). The transport
channel could contain a receptor for stop-transfer sequences and may
disassemble to allow integration of membrane proteins (Gilmore , 1993; Mize,
1986). Alternatively, termination may be nonspecific and only a consequence of
hydrophobicity. Davis and Model (1985) have used artificial hydrophobic
sequences to demonstrate that the hydrophobicity of a segment suffices to stop
transfer of the coliphage pili membrane protein. The hydrophobic noncleavable
signal sequence is structurally similar to the stop-transfer sequence. The most
significant difference between the two segments appears to be the location within
the protein.
Integral membrane proteins that span the lipid bilayer one time are
classified as type I , type II or type III (von Heijne, 1988). Type I proteins contain
. -
- the N-terminal cleavable signal sequence. The final topology is achieved by
cleavage of this signal and membrane integration by a C-terminal hydrophobic
stop-transfer sequence. Type II proteins also have an amino-terminal or internal
signal sequence, but this hydrophobic segment is not cleaved and serves to both
target and anchor the protein (Spiess and Lodish , 1986). Following insertion of
type II signals , and in the absence of a C-terminal anchor sequence, continued
elongation leaves the amino terminal residues exposed to the cytoplasm and the
terminal portion of the protein completely translocated into the lumen of the
ER. The unusual type III topology is achieved by an internal uncleaved signal-
anchor segment that adopts an orientation opposite to that of type II proteins: the
carboxy terminus remains on the cytoplasmic side of the membrane.
Multi-spanning proteins achieve their topology by a series of signal
sequences and membrane-anchoring stop-transfer sequences (Rothman et ai
1988). Insertion is initiated by the first signal sequence in an SRP-dependent
manner and only this first hydrophobic domain may be recognized by SRP
(Wessels and Spiess , 1988). Additional translocation following membrane
integration is facilitated by subsequent hydrophobic segments and may occur
spontaneously (Wickner and Lodish , 1985) or due to the alternating action of
uncleaved signal and stop transfer sequences (Rothman , 1988).
The NDV fusion protein , as well as many other viral fusogenic
glycoproteins , contains a third hydrophobic domain denoted the fusion peptide
(reviewed in White, 1990). Like stop-transfer and type II signals , these fusion
f)eptid contain over 20 uncharged residues and have the potential to form an
alpha-helix in the presence of lipids (White 1990; Brasseur, 1990). However, this
- segment is completely translocated across the ER membrane as indicated by
exposure on the surface of infected cells and secretion in the absence of the C-
terminal anchor (personal observation , Chapter II).
- -
The mechanism by which the fusion peptide fails to halt translocation has
been explored by several laboratories. Paterson and Lamb (1987) examined the
the abilty of the position to influence its membrane interactions. When the C-
-- terminus of an influenza hemagglutinin (HA) molecule (a type I protein) was
replaced with the SV5 fusion peptide and expressed in eukaryotic cells,
immunoprecipitation indicated that this chimeric protein was retained within the
cell as an integral membrane protein. In its natural position , the wild-type SV5
fusion domain was completely translocated. This result suggested that the fusion
domain is sufficiently hydrophobic to function as a membrane anchor when at the
terminus of a protein but not in an internal position.
In similar work, Davis and Hsu (1986) inserted the fusion peptide from the
Sendai F protein into an internal position of a secreted version of the coliphage
pil protein and found by immunoprecipitation that the fusion peptide also failed to
stop transfer in a bacterial expression system. This result led the authors to
suggest that the fusion peptide in viral proteins has evolved to be compatible with
translocation by keeping the overall hydrophobicity below an unknown threshold.
Although these studies indicated that the fusion peptide can be
translocated, they may not have detected all populations of the protein. Fusion
proteins that are anchored by the fusion peptide would likely be misfolded and
underglycosylated and may not be detected by antisera generated against
mature molecules. In both studies , protease digestion of proteins exposed on the
surface of isolated microsomal vesicle or bacterial spheroplast membranes was
used for determination of membrane topology. Unless the antisera used for
immunoprecipitation recognized the epitopes of the protein upstream of the
-- fusion peptide, this potential population may not have been detected by the
subsequent immunoprecipitation. Neither work addressed this issue.
An alternative system that overcomes these limitations when examining
. the topology of a protein is to utilize a cell-free translation system. Translation
that employs cytosolic extracts from wheat germ allows the translation of a single
species of mRNA to direct the synthesis of a single species of labeled protein.
When this translation system is also supplemented with microsomal membranes
derived from the ER , the proteins are translocated in a manner identical to that
observed in vivo (Katz and Lodish , 1979). Protein translocation can be identified
by post-translational processing reaction such as the addition of core
oligosaccharides and by signal sequence cleavage. The topology with respect to
the ER membrane can be determined by treatment with a protease to identify
protected and exposed domains. With these tools, all resulting toplogical species
can be examined.
Precursor rocessin . While the precursor fusion protein is in the ER
oligosaccharides are added , the molecule folds and intramolecular disulfide-
linked bonds form (McGinnes et ai , 1985). During transport through the Golgi
apparatus, the molecule undergoes a disruption of intramolecular disulfide bonds
and a conformational change (McGinnes et ai , 1985; Morrison et ai , 1987). The
precursor is often cleaved by host cell proteases and generates two disulfide-
linked polypeptides, F1 and F2 (see Figure 13; Scheid and Choppin , 1977;
Gotoh , 1992). Detergent binding and spectroscopic studies have indicated that
cleavage of the Sendai virus fusion precursor causes a conformational change,
exposes previously solvent- inaccessible hydrophobic domains, and causes an
increase in the alpha-helical nature of the protein (Hsu et ai , 1981). This cleavage
--cc positions the fusion peptide at the extreme amino terminus of the F 1 subunit and
. is essential for the fusogenic activity of the protein (Scheid and Choppin , 1974
1977; Gorman et ai , 1988).
The fusogenic proteins from the orthomyxovirus , retrovirus, and alphavirus
groups also are made as precursors (reviewed in White, 1990). For the fusion
. proteins of orthomyxovirus, paramyxovirus and retrovirus, the transmembrane
subunit retains the fusion peptide and associates with the amino-terminal subunit
through disulfide bonds or non-covalent interactions. Susceptibility to cleavage is
often a major determinant of the virulence of a virus (Webster and Rott, 1987).
The readily cleaved fusion proteins from virulent paramyxo- and
orthomyxoviruses contain two pairs of basic residues which are recognized by
the ubiquitous Golgi-associated protease furin (Gotoh , 1992; Barr, 1991;
Steineke-Grober, 1992). The avirulent strains have single basic residues at the
cleavage site and require a trypsin- like protease for activation in culture (Nagai
and Klenk , 1977; Gotoh , 1990).
Fusion activit . Eukaryotic expression of cloned viral glycoproteins has
allowed the assignment of specific biological activites to the individual
paramyxovirus glycoproteins. When the SV5 F cDNA was expressed in CV1
cells, the F protein caused syncytium formation (Horvath and Lamb , 1992).
However, accumulating evidence suggests that the remaining paramyxoviruses
require both an attachment and a fusion protein to induce cell-to-cell fusion.
Expression of the F and HN proteins of the bovine parainfluenza 3 virus from a
vaccinia virus vector indicated that the proteins must be coexpressed (Sakai and
Shibuta, 1989). In addition , the measles virus, mumps virus, HPIV-3, HPIV-2 and
NDV have shown a requirement for coexpression of F and HN (or H of the
morbillviruses) (Wild et ai , 1991; Tanabayashi et ai , 1992; Ebata et ai , 1991; Hu
and Compans, 1992; Morrison et ai , 1991). Furthermore , mixing experiments of
eells expressing F with those expressing HN suggested that the two
glycoproteins must be expressed in the same cell (Morrison et ai , 1991).
The results from these studies led to a determination of the specificity of
tlie HN fusion-promotion activity. Coexpression of the NDV F and the influenza
hemagglutinin proteins did not induce fusion , indicating that more than an
ftachment function is required of the HN protein (Morrison et ai , 1991). When
expressed from a vaccinia virus vector, the human parainfluenza virus type 2
(PIV2) HN could not function as a substitute for the genetically similar
parainfluenza type 3 (PIV3) HN protein (Hu et ai , 1992). Similarly, coexpression
ofthe NDV F and SV5 HN from an SV40 vector could not induce fusion (Horvath
et ai, 1992). These reports led to the suggestion that a specific interaction occurs
between the F and HN proteins to mediate cell fusion (Hu et ai , 1992; Sergei et
, 1993).
li::
fI'
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Functional domains. The question of which domains of the HN molecule
participate in fusion promotion have been the subject of several investigations. 
deletion mutant lacking nine amino acids at the base of the presumed stalk
region was deficient in fusion promotion but not hemadsorption (Sergei et aI.
1993a). Iorio and coworkers (1992) have shown that monoclonal antibodies
against HN residues 263, 287, and 321 inhibit fusion but not attachment. An
escape mutant of Sendai virus (SV) HN with a substitution at residue 420 was
selected with a monoclonal antibody that inhibits fusion (Portner et ai , 1987),
while a change at position 539 severely diminished the ability of a PIV3 HN
protein to promote fusion (Sakai and Shibuta , 1989). In contrast, early studies
with the fusion protein have focused on one region that appears to be directly
involved in the fusion event. Labeling with hydrophobic photoaffinity probes has
shown that the Sendai virus and influenza fusion peptides directly interact with
i"~
. target lipid bilayers (Novick and Hoekstra , 1988; Harter et aI. , 1989). Synthetic
4-L peptides that mimic the fusion peptide sequence inhibit both cell fusion and virus
penetration (Richardson and Choppin , 1983; Richardson et ai , 1980).
The significance of the fusion peptide in the fusion event is further implied
by its presence within the transmembrane subunit of fusogenic proteins from
diverse familes of enveloped viruses (reviewed in White, 1992). In addition , a
putative fusion peptide has been identified within the fusogenic sperm
glycoprotein, PH-30 (Blobel et ai , 1992). White (1992) has identified several
general properties of fusion peptides. The segments average 28 residues for
proteins with an amino-terminal fusion peptide and have an average
hydrophobicity value between signal (low) and transmembrane (high)
sequences. Most fusion peptides have a potential to form 'sided' helices with a
segregation of polar and nonpolar residues. The amino acid sequences of fusion
peptides are highly conserved within a virus family but not between families
(White, 1992). This suggests that the particular amino acids may have a non
sequence specific function in the fusion event. When the requirement for
sequence conservation was tested for a paramyxovirus , a functional assay
indicated that conservative substitutions can be tolerated while nonconservative
changes often disrupt cellular transport of the molecule (Horvath and Lamb
1992). In addition , changes that were expected to increase the alpha helical
nature of the peptide increased the fusion activity. Thus , hydrophobicity and
potential to form an alpha helix appear to be the only structural constraints placed
on this segment.
Evidence from several laboratories indicates that regions other than the
fusion peptide also may have critical roles for the fusogenic activity of the F
protein. Both Toyoda et al. (1988) and Portner et al. (1987) have shown that
monoclonal antisera against a cysteine rich region of the NDV and SV fusion
proteins, respectively, can inhibit fusion. Viral membrane proteins , as well as
most cellular glycoproteins , contain numerous disulfide bonds which are critical
C-' forfolding and stabilty of the mature protein (Doms et ai , 1993). Paramyxovirus
u - fusion proteins contain a cluster of seven conserved cysteine residues
- approximately 100 residues upstream from the transmembrane domain that may
form a series of cross- linked loop structures (Morrison and Portner, 1991). The
importance of this conserved cysteine-rich region in fusion was indicated when
synthetic peptides that inhibited fusion allowed the isolation of a mutant measles
virus with changes only in this cysteine region of F (Hull et al. 1987).
An additional determinant of fusogenic activity for F proteins may be
located downstream from the cysteine-rich region and adjacent to the
transmembrane domain. This sequence consists of a series of leucines occuring
every seven residues and another nonpolar residue in every fourth position (see
Figure 13; Buckland and Wild , 1989; Lamb , 1993). A comparable repeat
sequence is similarly positioned within the coronavirus fusogenic protein (Britton
1991). If these regions are displayed on an alpha-helical wheel , the leucines and
the fourth position amino acid align along one face of the helix
, and an
amphipathic nature of the helix is evident. This series of leucines is highly
conserved within the family of Paramyxoviridae and resides against a
background of apparently nonconserved residues. Mutational analysis by
Buckland and coworkers (1992) has indicated that maintenance of the leucine
residues is necessary for the biological activity, but not the oligomeric structure
of the measles virus fusion protein.
The NDV fusion proteins contain a second potential alpha-helical structure
that may playa role in fusion (Wang et ai
, 1992; Chambers et ai , 1990). The
segment is made up of six heptad repeats and occurs immediately downstream
from the fusion peptide. A potential helix is similarly placed within the fusion
proteins of coronaviruses, influenza viruses and retroviruses (Chambers et ai
1990). Mutations in this heptad repeat (a leucine zipper motif) of the the HIV 
env protein inhibited syncytium formation and infectivity (Chen et ai , 1993). The
repeat sequences within these proteins are predicted to form long amphipathic
. -
alpha-helices (Chambers et al 1990; Delwart et ai , 1990) and may obtain a coiled
coil conformation through association of the nonpolar faces (Harbury et ai , 1993).
X-ray crystallography studies have indicated that this helix of the nascent
influenza HA protein points toward the virion before acidic pH triggers a
conformational change (reviewed in Wiley and Skehel , 1987). This action may
relocate the fusion peptide toward the target membrane and allow formation of a
three-stranded coiled coil (Carr and Kim , 1993). This inducible conformational
change suggests that the native form of the HA molecule is a metastable
structure (Lamb, 1993). The fusion proteins of the paramyxoviruses, as well as
the coronaviruses and some retroviruses fuse membranes in a pH- independent
manner and the trigger for this activation is unknown (White 1990). However, by
analogy with the HA protein , this potential helical structure within the NDV fusion
protein may function to correctly position the fusion peptide.
Surface glycoproteins of virions are often subject to immune surveilance
and usually evolve sequence variation to avoid this attack. The evolutionary
conservation of these determinants within the fusion proteins of the
Paramyxoviridae family suggests that the amino acids in these regions are
dedicated to structural or functional roles of the mature protein and substitutions
may be lethal (Kingsbury, 1990). A number of these conserved elements of the
NDV fusion protein are examined in the following chapters of this thesis.
CHAPTER II
Materials and Experimental Methods
Viruses. The strain Australia-Victoria (A V), a virulent NDV strain , was
propagated and purified as described previously (Hightower and Bratt
, 1975).
Cells. Cos-7 cells were obtained from the American Type Culture
Collection. They were maintained in dulbecco s modification of Eagle s medium
(D-MEM) supplemented with 5% complement-inactivated fetal calf serum , 4.5 gm/I
glucose , nonessential amino acids , vitamins, 2 mM glutamine, 0. 17% NaHC03,
penicilin/streptomycin , and 20 nM sodium selenite.
Antibodies. Fu1 a is a monoclonal antibody that was generated against a
disrupted virion preparation enriched in the matrix protein and was a generous gift
of Dr. Mark Peeples. This antibody has been shown to react with mature F protein
but not the nascent molecule (Morrison et aI.
, 1987). Anti-NDV antibody was raised
in rabbits against UV- inactivated NDV virions (strain AV) and was also shown to
react with only mature protein (Sergei et ai
, 1993). Anti-F was raised against a
peptide consisting of the 29 C-terminal residues of the protein and was a gift from
Dr. Mark Peeples (Wang et ai
, 1992) and was also generated in the University of
Massachusetts Medical Center (UMMC) facilty.
Site Directed Muta enesis. To construct the single-stranded DNA template
the F gene was excised from pSP6Fst (clone 15) by using the Xbal and Sacl 
sites
in the cloning cassette positioned at the 5' and 3' ends of the coding sequence
respectively. This fragment was ligated into M13mp18 and used to transform TG1
(f. coli) cells. A single , white, phage plaque was picked and grown on TG 1 cells in
x TV medium (16 g/I bacto-tryptone , 10 g/I yeast extract S g/I NaCI). The resulting
phage stock was precipitated with PEG 6000, the protein coat was removed by
phenol extraction and the DNA was precipitated in sodium acetate and
isopropanol. The resulting template positioned the F gene in the negative sense
direction. Positive-sense oligonucleotides were synthesized by the DNA Facility of
UMMC. The oligonucleotides used for mutagenesis were , starting with the 5-prime
nucleotide: (L3A)GA T AAGGCAGAGGAAAG; (L4A)CAGCAAAGCAGACAAAGTC;
(L5A) CAATGTCAAAGCGAACAG; (dC49) CATTACCTAGATCGCTTT; (S473A)
CAACAACGCGA T AAGT AA TGC; (N485K) GGAAAGCAACAGCAAAC; (Fg)
CAAGA TAAACACCTCA TCC; (E482K) GGA T AAGTT AAAGGAAAGC. The
oligonucleotides were phosphorylated and annealed to the template.
Oligonucleotide-directed in vitro mutagenesis of M13mp18 DNA was achieved by
methods and reagents from Amersham. The L3A mutant template was mutated
further to create the L34A and L35A mutants. Similarly, the L4A template was used
to produce the L45A and, subsequently, the L345A mutants. Following synthesis
of the mutant DNA strand and the complementary DNA strand , the extraneous
single-stranded DNA was removed, and the resulting RF DNA was used to
transform TG 1 cells. The resulting phage DNAs were screened for the desired
mutation by sequencing. A 564 bp restriction fragment (Aval- Sacl) containing the
desired leucine mutations was ligated in the remainder of the wild-type F gene and
the entire fragment was sequenced. The Aval-Sacl fragment from L345A was
ligated into the remainder of A 140K and K155L to produce the A 140K/L345A and
K155UL345A mutants. Most cDNAs were shuttled between M 13, pSVL and pSP6
via the Xbal and Sacl sites positioned in the cloning cassette at the 5' and 3' ends
of the F gene , respectively.
uencin . The nucleotide sequences of mutants were verified by
sequencing methods and reagents from United States Biochemical. The template
'"'
mNA was denatured, an oligonucleotide primer was annealed upstream from the
jegion of interest , and DNA synthesis was initiated off the primer by the
bacteriophage T7 DNA polymerase (Sequenase , United States Biochemical).
Extension of the complementary strand occurred in the presence of (a-35S)-dA TP.
~~~
he labellng reactions were then terminated with a dideoxynucleoside
triphosphate of either GTP , CTP , A TP , or TIP , which lack the 3' hydroxyl group
necessary for DNA chain elongation. The reactions were stopped by the addition
of sample buffer, denatured and resolved on a 6% sequencing gel.
Plasmid Constructions. Full- length cDNA containing the entire coding
region of the NDV fusion gene (strain Australia-Victoria or AV) was assembled from
two overlapping clones , pTL831 and pTL438, using a common Xmal restriction site
as shown in Figure 1 A. These clones were derived and characterized as
previously described (McGinnes et aI. , 1986). The resulting pTLF contained G-
tails at the 5' and 3' ends generated by the cloning protocols and were considered
likely to be detrimental in cell-free transcription. The G-C tails were removed using
a BamHI site and a Mnll site located in the 5' and 3' noncoding regions,
respectively. Figure 1 B outlines the method used to remove the 5' and 3' G-C tails
to produce the pSP6Fst cDNA. From pTLF, the BamHI-BamHI (52 nucleotides), the
BamHI-Sphl (1545 nucelotides) and the Sphl-Mnll (97 nucleotides) fragments were
ligated into an pSP64 vector cut with BamHI and Smal. The mutant pSP6F13
cDNA resulted from the subsequent deletion of the 52 nucleotide BamHI restriction
fragment.
The mutant pSP6SF (sans fusion domain) was generated by deleting the
sequence between the sites at nucleotides 167 and 446 in pSP6Fst. From
P6Fst, the 1335 basepair Pvull (at nucleotide 446) to EcoRI fragment , the 1621
se pair EcoRI-Pvul vector fragment , and the 1508 basepair Pvul to Pvull (at
- -
-'4i
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1Icleotide 167) fragment were ligated. The 93-codon fragment removed from the
uSion protein sequence encodes amino acids 39 through 131 and includes the
irst 15 of the 26 amino acid hydrophobic fusion domain found at the amino
terminus of F 1 .
The plasmid pSP6FSS (sans signal sequence) was constructed by removal
af a 162 nucleotide Pstl-Pstl restriction fragment from pSP6Fst. The construct
deleted 68 codons from the 5' end of the wild-type fusion gene by forcing
translation initiation off the third natural methionine codon.
The plasmid pSP6MF was constructed by placing the 5' region including the
initiator methionine codon , from pSP6M (contains the NDV matrix protein cDNA;
McGinnes et aI. , 1987) 42 nucleotides upstream from the coding region for the
amino terminus of F 1. Construction involved cleaving at the Hinfl site at the fourth
base of the coding sequence for the NDV matrix protein and ligating to the Hinfl site
at nucleotide 362 of the NDV fusion protein cDNA. The 4-way ligation included the
1400 basepair pSP6 EcoRI-Bgll piece , the Bgil-Hinfl (at nucleotide 43) from
pSP6M , Hinfl (nucleotide 362) to Haell (nucleotide 764) from pSP6Fst, and Haell
(nucleotide 764) to EcoRI from pSP6Fst.
The pSP6dC91 plasmid (without leucine zipper motif) was constructed by
deleting a 182 basepair fragment between the EcoRV and Sphl restriction sites
found at nucleotides 1438 and 1620 , respectively. Plasmid SP6Fst was digested
with Sphl and the site was blunted with T4 DNA polymerase and further digested
with Bgii. Ligation of the 1478 nucleotide Sphl-Bgil fragment to the 3017
nucleotide pSP6Fst BglI-EcoRV fragment resulted in a frame-shift and a premature
translation termination. This deletion substituted 91 codons from the carboxy
terminus of the parental plasmid , including the leucine zipper and the
'''
ransmembrane cytoplasmic domains , with a new sequence (following the EcoRV
lfr;- ite) coding for the amino acids LPNCQAKGATKDLVMAWE. The plasmid
pP6SFdC91 was constructed similarly by ligating the BglI-EcoRV and Sphl
(biunted)-Bgli fragments isolated from pSP6SF. This construct lacked the coding
sequence for both the second and third hydrophobic domains.
For in vivo expression, the NDV genes were expressed in Cos cells using
tile SV-40 based expression vector, pSVL (Pharmacia). Most genes were ligated
into the Xbal and Sacl sites of the cloning cassette. Ligations were incubated at
room temperature for 4 hours in 50 mM Tris (Triis(hydroxymethyl)aminomethane),
10 mM MgCI2, 0. 1 % BSA , 5 mM DTT, and 1 mM A TP and 1 unit of T 4 DNA ligase
(Boehringer Mannheim Corp.). Proper construction of all cDNAs was verified by
sequencing as well as translation of mRNAs generated by transcription of the
resulting DNA with SP6 polymerase (Krieg and Melton , 1987).
DNA stocks. HB101 bacterial stocks were transformed with plasmid DNA
and grown from a single colony in a half liter of LB broth (10g/1 bacto-tryptone , 5g/1
yeast extract, 10g/1 NaCI , 1 mM NaOH) for 6 hours and amplified with
chloramphenicol (85 mg) for an additional 12 hours. Bacteria were pelleted and
the plasmid DNA was purified with the reagents and columns supplied with either
the pZ523 (5 Prime - 3Prime , Inc. ) or Qiagen maxi-prep purification kits.
Cell Free Transcri tion and Protein S nthesis. Full- length mRNA transcripts
of each cDNA were generated by linearizing the plasmids downstream from the
coding region with EcoRI. The purified DNA was transcribed with SP6 RNA
pOlymerase (Promega) according to a modified procedure which included capping
of the newly made transcripts (Krieg and Melton
, 1987). Transcription reactions
contained 0.5 mM each of A TP , CTP , and UTP; 0. 1 mM GTP; and 0.4 mM
7G(5' )ppp(5' )G. Translation reactions (25 f.l) using 30% (vol/vol) nuclease-
treated wheat germ extract and 18.75 f.Ci (35S)methionine followed previously
described methods (Erickson and Blobel , 1983). Wheat germ extract was
n supplemented with 25 mM creatine phosphate
, 1.8 mM ATP , 0.3 mM GTP , 0. 18 mM
-- of each amino acid excluding methionine , 25 mM HEPES (pH7.8), 64 f.g/ml
creatine phosphokinase , 250 mM spermidine , 3.2 mM dithiothreitol (DTT), 0.0016%
Nikkol , 7U/25 f.l RNasin (Promega), 0.9mM MgOAc , and 20 mM KOAc. Translation
reactions were incubated for 90 minutes at 24 C. Canine pancreatic membranes
stripped of SRP (KRM) and SRP were isolated as described previously (Walter et
aI., 1981a) and were the generous gift of Dr. Reid Gilmore. One f.l (1 pmol) of SRP
or SRP buffer (50 mM Triethanolamine,TEA; 500 mM KOAc, 5 mM MgOAc , 0.01%
Nikkol:' 1 mm DTT) and 1.5 f.l of KRM (1.5 equivalents) or KRM buffer (1 mM DTT
250 mM sucrose and 50 mM TEA) were added to each 25 f.l translation reaction.
To quantitate SRP translation inhibition , the M protein mRNA , generated from M
cDNA described previously, were added to a 50 f.l reaction containing the second
species of mRNA, and the mixture was split prior to the addition of SRP or SRP
buffer. The tripeptide Asn- Tyr- Thr (NYT) is used to inhibit N- linked glycosylation
and was synthesized and blocked as described previously (Welply et aI.
, 1983).
The acceptor tripeptide (gift from R. Gilmore) was added to membrane-
supplemented reactions to a final concentration of 400 f.M 10 minutes prior to the
addition of the mRNA. Translation products (5 f.l) were dissolved in 10 f.l of a
25% SDS and 0.5 M Tris pH 8 solution. Prior to loading the gel
, the samples
were boiled in the presence of 0. 1 M DTT for 5 minutes and alkylated with 56 mg/ml
iodoacetamide. To determine whether transcription in the presence of translation
affects protein translocation
, a transcription- linked translation assay was
developed. The transcription reactions using non-linearized plasm ids were
incubated at 41 oC for 30 minutes. Two microliters from this reaction was added
directly to the translation mix and transcription-translation was allowed to occur for
90 minutes at 22 C. To compare results from the wheat-germ system to those of a
mammalian system , a rabbit reticulocyte translation system was used following
protocols supplied by the manufacturer (Promega).
Protease Protection Assay
. Five microliter aliquots of each translation
reaction were diluted to 25 JlI with RSB (10 mM NaCI , 1.5 mM MgCI2, 10 mM Tris
pH 7.4) and proteinase K. Final enzyme concentrations ranged from 0. 200 Jlg/ml
and are indicated in figure legends. Digestions were for 60 minutes on ice and
were stopped by adding phenylmethylsulfonyl flouride (PMSF) to 10 mM. Samples
were TCA-precipitated , resuspended in sample buffer
, dissolved and boiled prior to
loading half of each sample onto the gels. To test for leakiness of the vesicles
preprolactin mRNA isolated from bovine pituitary (gift from R. Gilmore) was added
to the translation reaction.
Transient Gene Expression
. Several systems were employed to express the
cDNAs. For transfections requiring a high level of transfection efficiency, DEAE-
Dextran was used following a modification of the method of Levesque
, et al (1992).
Cos cells were plated on 35 mm plates (Falcon Primaria) at 2.5 x 105 cells 20
hours prior to transfection. The monolayers were 80% confluent at the time of
transfection. Two micrograms of DNA were mixed with 0.5 ml of a solution of
DEAE/Dextran (Pharmacia) suspended in Tris buffered saline (TBS; 25 mM Tris
base , 137 mM NaCI , 5. 1 mM KCI , 0.7 mM Na2HP04; pH 7.4) at 0.5 mg/ml. The
plates were rinsed once with TBS and the DNA was allowed to adsorb to the cells
at room temperature for 20 minutes then incubated at 37 C for one hour. The
DNA/Dextran mix was replaced with 1 ml of 100JlM chloroquine in OptiMem
(Gibco) and the cells were incubated at 37 C for an additional 5-6 hours. The
chloroquine was removed
, the plates were rinsed with TBS
, and 2 ml of Cos media
was applied. At 48 hours post-transfection , the cells were washed in TBS and cells
, Were 
lysed in 0.4 ml of lysis buffer (1% Triton X-100 , 2 mg/ml iodoacetamide, 1 mM
PMSF in RSB). Plates were scraped with a rubber policeman, the extract was
pulled through a 21-gauge needle 5 times , and centrifuged for 30 seconds to
remove nuclei. Extracts were stored at 4 C until use.
For Lipofectin transformation, Cos cells were plated at 2 x 105 24 hours prior
to transfection and were 50-60% confluent at the time of transfection. Ten III 
Lipofectin (Gibco) in 200 III of Opti-MEM (Gibco) was incubated with the DNA for 15
minutes then 0.3 ml of Opti-MEM was added. The assay was optimized for fusion
activity and required that 3 Ilg of F DNA and 1.5 Ilg of HN DNA be used. To
account for background fusion , 4.5 Ilg of pSVL DNA was transfected. The plates
were washed twice with TBS and the DNA/Lipofectin mixture was applied. The
plates were incubated for 6 hours , and the DNA mixture was replaced with 2 ml of
Cos media.
Fusion Assa . At 24 48 and 72 hours post transfection , the plates were
systematically scanned for areas of fusion. In each field of view, the number of
nuclei in every syncytia with 3 or more nuclei were counted for a total of 20
syncytia. Two individuals scored the plates and the numbers were averaged. An
index value was obtained by subtracting the average value obtained from pSVL
from the value for each assay.
Immunofluorescence. Cos cells were plated on glass cover slips in 35 mm
plates containing glass cover slips at 3.5 x 105 20 hr prior to transfection. To fix
cells , at 48 hours post transfection , the cells were washed in PBZ buffer (1 % fetal
calf serum, 0.2% NaN3 in PBS) and dried at room temperature. After 20 minutes,
the cover slips were placed in 95% ethanol and stored at - C. After a minimum
of one hour the slides were rinsed in PBS. Buffer PBZ was applied and plates
were stored a minimum of 16 hours at 4 C. For live cells, the plates were washed
in PBS and incubated with cold PBZ for one hour. All subsequent incubations
were performed at 4 C. One-half ml of primary antibody diluted 1: 100 in PBZ was
applied to the coverslips and incubation proceeded for 90 minutes at 4 C for live
cells or 30 minutes at room temperature for fixed cells. The unbound antibody was
removed by thorough washing in PBZ. Fluorescein isothiocyanate (FITC)
conjugated to anti-rabbit or anti-mouse IgG (Southern Biotechnology Associates)
was used at a 1:100 dilution. The coverslips were incubated on ice for 30 minutes
washed thoroughly in PBS and inverted onto slides treated with a drop of DABCO
(25 mg/ml triethylenediamine , 90% glycerol , in PBS),
. Radiolabelin . Labeling with (35S)methionine (100 JlCi/ml , 1450 Ci/mmol;
Amersham) was accomplished in methionine-free minimal essential medium
supplemented with nonessential amino acids and 10% dialyzed fetal calf serum.
For pulse-chase experiments, labeling was for times indicated in figure legends
and followed by the addition of complete Cos media.
Immuno reci itations. Ceillysates were incubated with a 1:100 dilution of
antibody for one hour at room term perature. The immune complexes were
precipitated with Immunobeads (Bio-Rad) to which goat anti-rabbit or anti-mouse
immunoglobulin antibody was covalently coupled to the micron-sized hydrophilc
(polystyrene) beads. Before use , the beads were prepared by washing once in 5
mg/ml BSA, twice in 1 mg/ ml BSA/PBS/ 0.5% NP40 and resuspended in 1 mg/ml
BSA at a concentration of 19 Jlg antibody/10 mg beads/ml. One hundred
microliters of beads were added to each sample and incubated on a shaker for 30
minutes. The beads were pelleted by spinning for 30 seconds in a microfuge, and
washed 3 times in wash buffer (0.5% NP-40, O.4%SDS in PBS). Samples were
resuspended in 80 JlI of sample buffer and divided into two equal portions.
Immediately before loading onto a gel, the samples were denatured by boiling 5
minutes (with and without 1 J.1 of B-mercaptoethanol; BME), 1 mg of iodoacetamide
was added, the beads were pelleted, and the supernatants were loaded onto a
10% SDS gel.
Detection of Cell Surface Molecules. After a pulse label and a
nonradioactive chase, monolayers were washed in ice-cold PBS (0. 15 M NaCI , 7.
mM K2HP04, 2.4 mM KH2P04) and incubated on ice with a 0.5 ml of a 1 :50
dilution of anti-NDV antiserum (heat inactivated at 56 C for 30 min) in PBZ. After 60
minutes, the unbound antiserum was removed by extensive washing in ice-cold
PBS. The cells were lysed in 0.5 ml of lysis buffer containing 1 % Triton-X 100 and
5% sodium deoxycholate. The monolayers were scraped with a rubber
policeman , the lysate was pulled through a 21-gauge needle several times, and
the nuclei were removed from the lysate by a 30 second centrifugation. The
immune complexes were precipitated with Immunobeads as previously described.
Sucrose gradients. To examine the oligomeric structure of the
glycoproteins, sucrose gradients were used. A linear gradient of 25% to 10%
sucrose (w/v) dissolved in RSB and 0. 1 % Triton X-100 was created using a
gradient maker to mix the 5 mls of each solution into a polyallomer 14 x 89 mm
centrifuge tube (Sarstedt). A 200 J.1 cushion of 2 M sucrose was positioned at the
bottom of the tube. Each 35 mm plate was lysed in 0.4 ml of RSB , 1 % Triton X-100,
10 mM iodoacetamide , and 1 mM PMSF. The lysate was homogenized by pullng
through a 21-gauge needle several times. Nuclei were pelleted by spinning in a
microfuge for 30 seconds. A total of 0.6 ml (1-1/2 plates) was carefully layered over
the gradient. The Iysates were fractionated by centrifugation at 38,000 rpm , at
, for 18 hours in an SW41 rotor. One-half ml fractions were collected from the
top of the gradient. Fractions were numbered beginning with fraction 1 at the
bottom and fraction 21 at the top. The pelleted material was dissolved in 90 f.1
, SDS-Tris sample buffer (6.25% SDS, 0.5M Tris pH 8), and 30f.1 was loaded on the
gels. Fractions were TCA-precipitated , and the pellets were dissolved by
incubating in 30 f.1 of SDS- Tris sample buffer at 50 C for 15 minutes. Prior to
loading, 15 f.1 of reduction mix (50% glycerol and 0.01% bromophenol blue) and 
f.1 of BME were added , the samples were boiled for 5 minutes , and 0.2 mg
. iodoacetamide was added. A marker of 0. 12 f.1 of NDV virions was loaded in the
first lanes. In most cases, fractions 15, 17, and 19 were omitted, as any molecules
that may sediment in those fractions were expected to be too small to be resolved.
- To calibrate the gradients , molecular weight protein markers (Boerhinger
Mannheim) were similarly processed, and the resulting gels were stained with
Coomassie Blue stain.
Polyacrylamide Gel Electrophoresis Electrophoresis on SDS-
polyacrylamide slab gel was carried out by the procedure of Laemmli (Laemmli
1970) with the modifications of Morrison et al (Morrison and Ward, 1984). For the
cell-free translations , proteins were resolved on 12% polyacrylamide-SDS gels.
For all other assays, samples were resolved on 10% gels. Following
electrophoresis, the gels were subjected to western analysis or fixed , dried and
subjected to autoradiography using Kodak X-Omat AR X-ray film. For
immunoprecipitations, gels were treated with PPO. A BetaScope (Betagen) was
used for quantitation of (35)S-methionine labelled products. Rainbow markers
(Amersham) were used for determination of molecular weights.
Western Analysis. Following electrophoresis , the gel was equilibrated in
transfer buffer (25 mM Tris base, 192 mM glycine and 5% methanol) for 20 minutes.
T'he hydrophobic membrane Immobilon PVDF (Milipore) was pretreated with
methanol and also equilibrated with transfer buffer. The proteins were transferred
from the gel onto the membrane while immersed in transfer buffer at 100 mA for at
least 14 hours. To reduce nonspecific signals , the blot was soaked in 10% (w/v)
non-fat powdered milk (dissolved in wash buffer: 0.4% Tween-20 in PBS) for 4
hours. The blot was washed 3 times and probed with the primary antibody (1 :2500
in wash buffer) for 90 minutes at room temperature. Following 3 washes , the blot
was treated with a 1 :40 000 dilution of horseradish peroxidase-conjugated anti-
. rabbit IgG (Boehringer Mannheim Corp. ) for one hour. The blot was allowed to
wash overnight at 4 C. The blot was treated with the luminol-based ECL reagents
(Amersham) for one minute, drained , wrapped in plastic wrap and immediately
detected by placing against fim (Kodak X-AR). To obtain adequate signals,
exposures were varied from 1-120 seconds.
Construction ression and urification of tr E fusion roteins. To
generate specific antisera, segments of the fusion protein gene were fused to the
amino terminus of the trpE gene under the control of the tryptophan operon of
E.coli. The genes were expressed in HB101 cells and the resulting protein is
insoluble and was purified from the bacterial lysate as previously described
(Koerner et aI. , 1991). Constructs were made with four segments from the coding
sequence for the fusion protein. Nucleotides 76-1715 (BamHI-Clal) and 76-445
(BamHI-Pvull) were ligated into the BamHI and Clal sites of pATH1 to generate the
pATH-E (entire) and pATH-5' proteins, respectively. Nucleotides 750- 1715 (Pvull-
Clal) and nucleotides 202-801 (Hindll-Hindll) were inserted into the pATH 2 Smal
restriction site to create pATH-3' and pATH- , respectively. Approximately 250 j.g
of semipurified protein was electrophoresed on eight percent polyacrylamide-SDS
gels. The appropriate bands were excised and homogenized in an equal volume
of PBS. Freunds complete adjuvant was added (25%v/v) and 6 subcutaneous
injections were made along the back and hips of each rabbit. After 4 weeks , 150
JIg of protein mixed with Freunds incomplete adjuvant (25%v/v ) was used to boost.
Two weeks after boosting, the rabbits were bled weekly.
Chemical cross-linkin . To analyze protein-protein associations, the cell
surface proteins were chemically crosslinked prior to cell lysis. Intact monolayers
- were washed twice in PBS. The crosslinker was applied at a final concentration of
- n
10 mM in PBS for 30 minutes at 4 C. The reaction was stopped by washing once in
TBS followed by 25 mM ethanolamine for 2 minutes. The noncleavable
crosslinders, DMS, DMA , and DMP were tested. The thiol-cleavable crosslinker
DTSSP (all from Pierce) was also used. The plates were washed , lysed in Triton
100 and deoxycholate, and immunoprecipitated or subjected to western
analysis.
CHAPTER III
CELL-FREE TRANSLATION AND MEMBRANE TRANSLOCATION OF THE
FUSION GLYCOPROTEIN OF THE NEWCASTLE DISEASE VIRUS
INTRODUCTION
Newcastle disease virus (NDV) is a paramyxovirus whose viral envelope is
derived from the infected cell membrane and contains the virally-encoded fusion
glycoprotein. The fusion protein mediates membrane fusion between virions and
the target cell and also between infected and un infected cells (Bratt and Gallagher
1969; Scheid and Choppin , 1974). The complete nucleotide sequence for the
NDV fusion protein gene predicts an amino acid sequence with hydrophobic
domains at the amino terminus and near the carboxy terminus (McGinnes and
Morrison , 1986). This arrangement is typical of type I membrane glycoproteins
proteins with the amino terminus outside the plasma membrane and the carboxy
terminus, cytoplasmic.
The amino terminal hydrophobic sequence of type I membrane proteins
corresponds to an endoplasmic reticulum-specific targeting sequence that is
recognized by the signal recognition particle (SRP) upon emergence of the
nascent chain from the large ribosomal subunit (for a review see Lingappa
, 1989).
Further elongation of the polypeptide is halted or markedly diminished until the
SRP-ribosome-nascent chain complex is targeted to the endoplasmic reticulum
membrane via interaction with the membrane bound SRP receptor (for review see
Walter et aI., 1984). SRP is displaced from the signal sequence by the SRP
receptor in a GTP-dependent reaction that leads to the subsequent insertion of the
- nascent chain into the membrane (Connolly and Gilmore , 1989). Polypeptides
undergoing translocation are in direct contact with a 39 kD membrane glycoprotein
termed the signal sequence receptor (Wiedman et aI., 1987; Krieg et aI. , 1989).
Translation resumes, and the polypeptide is translocated across the membrane
until the hydrophobic stop transfer sequence of the transmembrane protein
emerges from the ribosome (Yost et aI. , 1983). Further translocation of the
polypeptide is abolished when the stop transfer sequence is inserted into the
membrane. Unlike the amino terminal signal sequence that is removed by the
lumenal enzyme signal peptidase (Evans et aI. , 1986), the hydrophobic stop
transfer sequence is retained to function as the transmembrane spanning segment
of the mature type I integral membrane protein.
Stop transfer sequences derived from type I membrane proteins have been
to function as signal sequences in certain contexts. A stop transfer
sequence can be recognized by SRP and act as a noncleavable signal sequence
it is placed at the extreme amino terminus of a polypeptide (Mize et aI. , 1986;
et aI. , 1987). A cleavable signal sequence, however, cannot replace a stop
transfer sequence as a transmembrane span when it is placed near the carboxy
terminus of a type I membrane protein (Rothman et aI. , 1988). N-terminal signal
sequences are less hydrophobic than stop transfer sequences, and this may
for the failure of a signal sequence to halt translocation of subsequent
of the polypeptide when it is postioned at the end of a membrane protein.
The amino acid sequence of the fusion protein contains a third hydrophobic
omain of 26 uncharged amino acids beginning 117 residues from the amino
terminus (McGinnes et aI. , 1986). This additional hydrophobic region , often called
the fusion peptide (Morrison , 1988), is located at the amino terminus of the 
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portion of the mature protein. The paramyxovirus fusion protein is synthesized as a
- biologically inactive precursor, FO, which is subsequently cleaved by a host cell
protease into two disulfide- linked polypeptides, F1 and F2 (Scheid and Choppin
1974, 1977). This cleavage is necessary to activate the fusion activity of the protein
. -
required for infection (Scheid and Choppin , 1974 , 1977). A comparison of the
amino acid sequence of the amino terminus of the NDV F1 subunit with that of
other paramyxoviruses indicates that the sequence of this hydrophobic region is
highly conserved and is , therefore, likely to be functionally important (Richardson et
aI., 1986; Morrison and Portner, 1991).
The hydrophobic fusion peptides in viral fusogenic glycoproteins are
intermediate in hydrophobicity relative to signal sequences and stop transfer
sequences (White, 1990). Also, the fusion peptides of the paramyxovirus fusion
proteins are preceeded by positively charged amino acid residues , typical of stop
transfer sequences of type I membrane proteins and signal/anchor sequences of
type 2 membrane proteins (Figure 24; von Heijne, 1988). However, previous
, reports have indicated that the fusion peptides are completely translocated across
the ER membrane during cellular biosynthesis (Paterson and Lamb , 1987; Davis
and Model , 1985; Davis and Hsu , 1986). In addition , antigenic determinants on
both sides of this hydrophobic domain are exposed on the external surface of the
. virion (Toyoda et ai , 1988). However, when the fusion sequence of the simian virus
5 (SV 5) fusion protein was moved to the extreme carboxy terminus of the influenza
virus hemagglutinin and expressed in vivo , it served to anchor the protein in
membranes (Paterson and Lamb , 1987). The SV 5 fusion sequence can also act
as a signal sequence in vivo when placed near the N-terminus of a hybrid protein
(Paterson and Lamb , 1990) Given these observations, it was of interest to examine
the behavior of the NDV fusion sequence using a cell free system.
This work characterized the membrane insertion of the fusion protein in a
cell-free system. To identify the topogenic signals of the protein, deletion mutants
were constructed in which each hydrophobic segment was deleted. Expression of
hese constructs in wheat germ extracts containing ER-derived membranes
Indicated that the fusion protein behaves like a type I integral membrane
glycoprotei . Both the amino terminal 13 amino acids and SRP were necessary for
efficient targeting to membranes and translocation. The carboxy terminal region
remains untranslocated, consistent with the notion that the third hydrophobic
domail) is a stop transfer/membrane anchor sequence. Further, the fusion domain
by itself shows little signal sequence activity but does have stop-transfer activity in
its normal position.
RESUL TS
Plasmid Constructions. The strategy used for construction of the full-length
coding region of the fusion gene in pSP64 is shown in Figures 1A and 1 B. The full-
m length fusion gene was assembled in pBR322 by using a common Xma I restriction
site in an overlapping region of two fusion protein gene specific clones to produce
- -
. pTLF. The 5' and 3' G- C tails generated by the cloning protocols were removed as
shown in Figure 1 B to generate pSP6Fst. The coding region for the 553 amino
acids of the fusion protein lies within the 5' Bam HI site and the 3' Mnl I sites , sites
used to eliminate the G-C tails.
utants which eliminated each of the hydrophobic domains of the fusion
protein were constructed as described in Materials and Methods and Figure 2.
Three mutants deleted part or all of the amino terminal signal sequence. The
pSP6F13 mutant deletes nucleotides 24-75 removing the methionine codon from
the amino terminal signal sequence. Translation is forced to initiate at the second
methionine codon in the coding sequence resulting in the deletion of the first 13
amino acids of the protein. The pSP6FSS mutant deletes the amino terminal
signal sequence including the first two methionine codons of the coding region of
the fusion protein gene. This construct forces translation to initiate at an internal
methionine 68 codons downstream from the original translation start site. The
pSP6MF mutant deletes the first 103 codons and initiates translation from a
methionine codon placed 42 nucleotides upstream from the sequence encoding
the hydrophobic fusion peptide. The pSP6SF cDNA deletes much of the second
hydrophobic domain of the fusion protein by removing nucleotides 168-446, which
encode amino acids 39 to 131 , including the first 15 amino acids of the fusion
peptide. The coding region for the third hydrophobic domain was deleted from the
'" ,
F and SF cDNAs by introducing a frame shift mutation 91 codons upstream from
. the carboxy terminus to produce the dC91 and SFdC91 cDNAs , respectively.
Cell Free Translations. In order to characterize the proteins encoded by the
pSP6F t, pSP6F13, pSP6FSS, pSP6MF , and pSP6SF DNAs , the linearized DNAs
were transcribed using SP6 polymerase, and the mRNAs synthesized were used to
direct protein synthesis in a cell-free wheat germ extract. The resulting
(35S)methionine- labelled products are shown in Figure 3 (largest molecular weight
species in each lane). The pSP6Fst, pSP6F13, pSP6FSS, pSP6MF , and
pSP6SF-derived transcripts encode full- length products with calculated molecular
weights of 59, 57. 48, and 49 kD , sizes expected for molecules of 553 (wild
type Fprotein), 540 (F13), 485 (FSS), 451 (MF), and 460 (SF) amino acids,
respectively (Figure 3). The synthesis of the FSS and F13 proteins indicates that
the translational machinery was able to recognize and initiate synthesis at normally
internal methionine codons.
Translation Inhibition b SRP. Protein sequences which function as signal
sequences bind SRP , often resulting in inhibition of translation in the absence of
microsomal membranes (Walter et aI. , 1981 c). To explore sequences in the fusion
protein which can bind SRP , the mRNAs derived from the wild type and mutant
cDNAs were translated in the presence of SRP. The NDV matrix (M) protein mRNA
was added to each reaction to monitor nonspecific inhibition of translation by the
SRP preparation. To control for consistancy in sample loading, the M protein
mRNA was added to the reaction , and the mixture was split prior to the addition of
SRP or SRP buffer. As shown in Figure 3, when SRP is added to the translation
reaction , a significant reduction in wild-type F protein and SF protein synthesis
Occurs (lanes 2 vs. 3 and 10 vs. 11; Table I). This result is compatible with the
existence of a signal sequence at the amino terminus of both proteins. The protein
F\13 lacks the first 13 amino acids of the amino terminus and, as shown in Figure 3,
!;,
tttredegree of translation inhibition due to SRP is significantly less than that of the
- . n
rbducts containing the wild-type amino terminus. The protein FSS lacks the entire
---
amino terminal signal sequence but retains the internally located hydrophobic
fusion peptide 48 amino acids downstream from the amino terminus. It was
possible that this remaining domain might be recognized by SRP. However, when
SRP is added to the FSS translation reaction , little inhibition of synthesis is
observed (lane 6 vs. 7, Table I). Also, SRP had little effect on the synthesis of the
MF product. Lack of inhibition of MF by SRP was somewhat unexpected. The
position of the hydrophobic domain at the amino terminus of the MF protein is
similar to the hydrophobic signal-anchor of type II membrane proteins. Since the
membrane anchor of type II glycoproteins bind SRP , it was expected that in its new
position , the fusion peptide might also bind SRP.
The extent of SRP inhibition of protein synthesis of the wild-type and the four
mutant fusion proteins was quantitated in two separate experiments (Table I).
These results indicate that the first 13 amino acids are required to maintain the
degree of SRP-mediated translation inhibition seen with the fusion protein. Also, in
the absence of an amino terminal signal sequence, the second hydrophobic region
was not efficiently recognized by SRP as indicated by the lack of translational
inhibition.
Membrane Insertion of the Fusion Protein. The translocation of the wild type
and mutant proteins was explored by adding microsomal membranes (derived from
pancreatic ER) to the translation reaction (Walter et aI.
, 1981 b). As shown in Figure
, the addition of microsomal membranes stripped of SRP (KRM) has no significant
effect on the wild type translation product (lane 1 vs. 2). However, when SRP is
also added, several products of lower mobility are synthesized (lane 3). These
new products are likely glycosylated forms of the fusion protein. The fully
glycosylated fusion protein was previously reported to migrate as a 66 kD protein
(McGinnes et aI. , 1985). Translation of the SF mRNA in the presence of SRP and
KRM (lane 15) also yielded a product with reduced mobility, indicating that this
mutant protein has maintained the ability to be properly translocated and
processed. Translation of the F13 mRNA in the presence of SRP and membranes
also resulted in the synthesis of a species of lower mobility. The efficiency of F13
translocation was significantly lower than for the two constructs that retained an
intact signal sequence. In contrast, translation of the FSS mRNA in the presence of
KRM and SRP did not result in a new polypeptide (lanes 9-11). Thus, using
glycosylation as an indicator for translocation , the FSS protein is not translocated.
To determine whether the the FSS protein may behave differently in a more
homologous system , the FSS mRNA was translated in the presence of membranes
using a reticulocyte lysate system and again remained unglycosylated (not shown).
Like the FSS protein , the MF protein behaved similarily in both the reticulocyte (not
shown) and wheat germ translation system and did not appear to be translocated
(lanes 17-19). However, on a longer exposure of the autoradiogram a very small
amount of a glycosylated MF species was detectable.
Glycosylation and Signal Sequence Cleavage of the F protein Constructs.
The tripeptide Asn-Tyr-Thr (NYT) was used to explore signal sequence cleavage of
the products of the cell free reactions. This tripeptide inhibits N-linked glycosylation
by competition for the glycosylation machinery within the membrane vesicles
(Welply et aI. , 1983). In the absence of translocation NYT has no effect on the
translation products (Figure 4 , lanes 11 vs. 12 and 19 vs. 20). When NYT, SRP and
membranes were present during translation of the F, F13 and SF mRNAs , the
products of lower mobility were not synthesized, indicating that these polypeptides
were indeed the result of glycosylation (Figure 4 , lanes 3 vs. 4 , 7 vs. 8, and 15 vs.
16). Translocation of the wild type , F13 and SF proteins in the presence of NYT
resulted in products of increased mobility (lanes 4 , 8 and 16). This result was
consistent with the cleavage of the amino-terminal signal sequence and
characteristic of secretory and integral membrane proteins. Signal sequence
cleavage of the NDV fusion protein has been previously reported to occur between
serine 31 and leucine 32 (Gorman , et aI. , 1988). The processed F and F13
- -
products appear to have the same mobility, suggesting that the first 13 amino acids
of the fusion protein are not necessary for recognition and cleavage by signal
peptidase. Combined results from the F, SF and FSS proteins indicate that all of
the signals necessary for targeting and translocation of the wild-type F protein are
contained within the first 39 amino acids.
Taking into account signal sequence cleavage of 31 amino acids from the
fusion protein , the difference in mobility between the most highly glycosylated and
unglycosylated species of 15 kD is consistant with the addition of 4 to 5 high
mannose oligosaccharides. The sequence of the fusion protein contains 5 N-
linked glycosylation sites preceding the presumed cytoplasmic domain. Thus
most or all of the sites are likely used in the cell free reactions. A consistent
,,-
observation was that the efficiency of glycosylation of the wild type F protein was
less than that of the SF protein (Figure 4 , lane 3 vs. 15). However, the efficiency of
signal sequence cleavage appeared comparable (Figure 4 , lanes 4 and 16). The
significance of these observations will be discussed below.
Protease Protection. To explore the topology of the wild-type F protein with
respect to the membrane , translocated proteins were digested with proteinase K.
For estimation of molecular weights, molecular weight markers were used to
calibrate the gels. Digestion of the translocated and fully glycosylated form of the
fusion protein resulted in protection of a polypeptide reduced in size by
;0;t
. approximately 3000 daltons (Figure 5, lane 4). In addition , a small fragment with
u a
n approximate molecular weight of 21 kD was also protected (see dot , Figure 5,
lane 4). The product of translation in the absence of membranes and SRP was
, .
completely sensitive to protease (lanes 1 vs. 2). When detergent was added to
solubilize the membranes, the protein was again entirely digested (lane 5). This
result indicated that the fusion protein fragments seen in lane 4 were protected
from digestion by the membrane vesicle and were not in a protease resistant
conformation.
The second hydophobic domain (fusion sequence) of the F protein appears
hydrop,hobic enough to act as a stop transfer sequence , although previous reports
indicate that during translocation of the Sendai virus nascent F protein , this domain
is completely transported into the lumen (Davis and Hsu , 1986). To determine
whether the membrane topology of the fusion protein would change in the absence
of this domain , the SF protein was synthesized in the presence of membranes and
. digested with proteinase K. As shown in Figure 5, the fully glycosylated SF protein
Hke the wild type, was reduced in size by approximately 3000 daltons upon
, proteinase K treament (10 vs. 11). However, the 21 000 dalton protected fragment
seen with the wild-type F protein is not produced. Protease treatment of the MF
and FSS products translated in the presence of membranes results in complete
digestion of both proteins. The very small amount of glycosylated MF protein
detected was protected from protease digestion (not shown).
As noted above, digestion of the wild-type F protein resulted in a small 21 kD
pOlypeptide as well as the larger protected species. This observation led to the
speculation that the fusion domain may make the vesicles permeable to the
protease. In order to test this idea, the mRNA for the F and SF was cotranslated
with mRNA for the secretory protein preprolactin. As shown in Figure 6, the amount
of prolactin recovered after proteinase K treatment is not significantly diminished in
reactions containing either F or SF mRNA. Thus the existence of the 21 kD
polypeptide after protease digestion cannot be attributed to membrane leakiness.
Sto Transfer Function of the C-terminus. After protease digestion , the
existence of a species with only a small reduction in size from the fully glycosylated
fusion protein and the SF protein indicated that some of these molecules contained
an internal domain near one end of the molecule that stopped translocation. The
third hydophobic region of the fusion protein is comprised of 28 amino acids
located 31 residues from the carboxy end of the molecule and is predicted to
function as" the stop transfer sequence. To verify that the carboxy terminus of the
fusion protein is susceptible to protease, the 3' region of pSP6Fst DNA was altered
resulting in synthesis of a protein missing the third hydrophobic domain, as well as
the cytoplasmic domain. Transcripts from the resulting pSPdC91 were translated
in the presence of membranes and SRP. Following translocation of the truncated
fusion protein, digestion with the protease indicated that slower migrating
glycosylated proteins are completely inaccessible to the enzyme (Figure 7, lane 3).
Deletion of the carboxy terminus removes the protease-sensitive site found in the F
protein. It is likely that the carboxy terminal region of the wild-type F protein and is
exposed because the third hydrophobic domain serves as a stop
transfer/membrane anchor sequence. There is a product produced in the
presence of membranes that appears to be cleaved and unglycosylated (see dot
lane 2) and is considerably reduced in amount by protease treatment (lane 3). 
addition , after protease digestion , a new polypeptide of approximately 21 kD
appeared (dot , lane 3). The pSP6SF mutant (missing the fusion peptide) was
similarily truncated, and the translocated products from this construct were fully
resistant to digestion (Figure 7, lanes 6 vs. 7). 
No small 21 kD fragment was
observed, and the signal sequence cleaved, yet unglycosylated form of the protein
was protease resistant.
Premature sto transfer behavior of a mutant fusion protein. The previous
result suggests that a population of the wild-type F protein molecules are anchored
in the membrane at a position upstream from the proposed transmembrane region
near the carboxy-terminus. If the hydrophobic fusion peptide were functioning to
stop protein translocation, this population of molecules would halt translocation at
the fusion sequence as depicted by form 2 in Figure 10. As there is only one
g1ycosylatio site prior to the fusion domain, translocation of this population would
result ina species of molecules whose molecular weight would increase by only
about 3 kD. Unfortunately, the loss of the cleavable signal sequence of about 3 kD
would "mask" this population, and they would comigrate with unmodified,
previously untranslocated, molecules. To test this hypothesis, a mutant was
designed to create an additional glycosylation site upstream from the fusion
domain. The resulting pSP6Fg mutant was translated in the presence of
membranes and subjected to the protease protection assay. As shown in Figure 8,
a small amount of the Fg molecules are fully glycosylated at 5-6 sites. These
molecules have a slight increase in mobility following the protease treatment. This
is expected from a population of fusion molecules anchored at the C-terminus and
having a small domain accessible to the protease. Secondly, close examination
revealed a novel band that runs slightly above the unglycosylated species and
appeared to be preferrentially synthesized in the presence of membranes (lane 9).
Following protease digestion , this novel population of Fg molecules appears to be
completely accessible to the protease (lane 10).
As suggested above , if a population of these molecules were anchored at
the fusion sequence, they would be glycosylated at two sites. Following protease
digestion, only the amino terminal portion of the molecule would be translocated
(and glycosylated). This portion would show protease protection , and result in the
detection of a 24 kD species glycosylated at two sites for Fg or a 21 kD species
glycosylated at one site with the wild-type protein. Protein fragments of mobilities
consistent with this reasoning are protected from the protease as indicated in lanes
4 and 10. If translocation occurred in the absence of glycosylation, these
fragments from the F and Fg protein would have the same mobility. When the F
and Fg molecules are synthesized in the presence of both membranes and the
glycosylation inhibitor NYT, both F and Fg have two protected species of the same
mobilities, approximately 17 and 55 kD , protected from the protease (lanes 6 and
12), corresponding to the partially translocated and fully translocated molecules
respectively. Combined , these results indicated that translocation of the fusion
protein in vitro results in populations of molecules with differing membrane
topologies as shown by forms 1 and 2 in Figure 10. To estimate the percentage of
F molecules that were partially translocated , and taking into acount that the larger
species would have 2-3 times the amount of (35SJ-methionine label , quantitative
densitometry of the two protected F species suggested that over 60% of the
molecules were partially translocated as depicted by form 2 in Figure 10.
Furthermore , translocation in the presence of NYT indicated that glycosylation was
not a factor in determining membrane topology.
Topology of proteins synthesized in vivo. To determine whether the fusion
protein behaves similarly in cells, intact membrane vesicles from (35SJmethionine-
labelled , NDV- infected cells were isolated and subjected to protease digestion. 
using pulse- labelled extracts, only the newly synthesized, or ER-associated
molecules would be detected. As shown in Figure 5, the fusion protein synthesized
in infected cells (see dot, lane 6) has a small terminal domain that is sensitive to
digestion at 20 ug/ml protease (compare lanes 6 and 7). The remainder of the
molecule is resistant to digestion even at 200 ug/ml of protease (not shown).
Protection of a 21 kD band could not be detected.
Since it was possible that the previous experiment might not detect the 
kD protected fragment, the topology of the protein was further investigated. The
mutant DNA, dC91 , was subcloned into the pSVL vector and the protein was
expressed in Cos cells. As noted previously, the dC91 mutant was found to be
anchored in membranes by the fusion sequence when synthesized in the cell free
system. If this occured in the cell , the protein might be transported through the cell
and be detectable at the cell surface. When dC91 was tested for surface
expression by immunoflouresence, it was detected although at very low levels (not
shown). To further evaluate the surface expression of dC91-expressing Cos cells,
the cells were subjected to a cell surface assay. In this assay, the cells were
radiolabelled, chased with cold medium and the cell surface was probed with a
polyclonal antibody generated against virion F protein. The immune complexes
were precipitated and the samples were analyzed by SDS-PAGE. Under these
conditions , no dC91 was detected on the cell surface (not shown).
If dC91 was not membrane-anchored, it would likely be secreted from the
cell. To determine if dC91 is secreted , transfected cells were subjected to a pulse-
chase experiment. Both the cell- lysate and supernatants were analyzed by
immunoprecipitation with an anti-F monoclonal antibody (Fu1 a). As shown in
Figure 9, lane 10, the protein can be found in the supernatant by 2 hours. There is
a species that remains cell-associated even with a 6 hour chase (not shown), but, it
migrates consistent with a fully glycosylated molecule , indicating that the molecule
is completely translocated. The reason for the decreased mobility of the secreted
form is unknown. In addition , the wild-type protein is totally cell-associated (lanes
14 and 16)
Proteins precipitated with anti-F antisera and electrophoresed under
reducing conditions resolve into two major bands as shown in Figure 9 , lanes 9-16.
This result would occur if the fusion proteins are cleaved into the F1-F2 subunits as
. occurs with the wild-type protein as it leaves the Golgi. As opposed to the wild-type
F, the dC91 is secreted (lanes 1 0 and 12 versus 15 and 17). The fully processed
F1 subunit of dC91 would be predicted to have the same electrophoretic mobility
as an uncleaved, underglycosylated dC91 species which would result from partial
translocation. To distinguish between the F1 subunit and an underglycosylated
partially translocated form , the immunoprecipitates can be resolved without
reducing agents. This wil allow any F 1-F2 subunits to remain disulfide-linked and
will have the same mobility as any uncleaved precursor dC91 protein (60 kD). If an
underglycosylated species (form 2 in Figure 10) is detected , it will have a predicted
molecular weight of about 48 kD , and will also be detected under nonreducing
conditions. When the immunoprecipitates from both the ceillysates and the
supernatants were run under non reducing conditions, only one band , migrating
, consistant with a 60 kD species , was detected (Figure 9, lanes 1-3). These results
suggest that the F protein sythesized in vivo undergoes only one form of membrane
insertion.
As mentioned above, the in vivo-expressed wild-type F1 subunit may
comigrate with partially translocated , underglycosylated , precursor molecules.
Thus, it would be useful to employ a mutant fusion protein that does not undergo
cleavage during transport through the cell. The mutant fusion protein F117L was
found to be suitable for this analysis (Morrison et ai , 1993). By using western blot
analysis of cells expressing this non-cleavable mutant, any F1-sized molecule
would represent an underglycosylated species of F. 
When this mutant was
examined, only the species consistent with a fully glycosylated molecule was
detected (see Figure 28, p. 110).
DISCUSSION
Cell-free translation of mRNAs derived from a full length fusion protein gene
and deletion mutants has allowed characterization of the topogenic signals of the
fusion protein. Translation of the wild type mRNA in the presence of SRP
resulted in an inhibition of fusion protein synthesis, indicating the binding of SRP to
a signal sequence in the nascent chain. The presence of both SRP and
membranes in the reaction resulted in the appearance of a new product which
comigrated with the fully glycosylated protein synthesized in NDV infected cells.
The us of the glycosylation competitor, NYT, revealed that this new product was
the glycosylated form of the fusion protein. The use of NYT also demonstrated
signal sequence cleavage of the fusion protein. Thus, in the cell-free system , the
fusion protein is translocated and glycosylated with concomitant signal sequence
cleavage.
Removal of the first 13 amino acids from the fusion protein , including three
proline and two basic residues , reduced the ability of the F13 product to interact
with SRP , and loss of this property may be directly responsible for the reduced
amount of translocation of F13 as indicated by glycosylation. The addition of
membranes and NYT to the reaction indicated that the cleavage site recognized by
signal peptidase is not dependent on the first 13 amino acids of the fusion protein.
This mutant as well as FSS, discussed below
, show that the first hydrophobic
domain of the fusion protein is an ER-targeting signal sequence.
The mutants FSS and MF were constructed primarily to determine whether
e second hydrophobic domain
, the fusion sequence, could function as a signal
sequence in the absence of the normal amino terminal signal sequence. The
fusion domain of the FSS construct is preceded by 48 amino acids , so the protein
encoded resembles a type II membrane protein with respect to the location of the
first hydrophobic domain. The signal/anchor domain of type II membrane proteins
remains uncleaved upon membrane integration and serves to anchor the protein in
the bilayer with the amino terminus of the protein exposed to the cytoplasm (for a
review see Wickner, 1985).
In contrast to the wild type fusion protein , synthesis of the FSS protein was
not significantly inhibited by the presence of SRP. Thus the fusion sequence in this
construct likely has litte ability to bind SRP. Further, the protein was not
glycosylated nor protected from protease digestion when membranes were added
to the reaction. The lack of SRP inhibition of FSS synthesis could have been due
to the length of the sequence preceding the hydrophobic fusion domain which
might have sterically hindered an interaction with SRP. This possibilty was tested
with the pSP6MF construct which encodes a protein with only 14 amino acids
preceeding the fusion domain. Results with this construct were similar to that
obtained with the FSS protein. Inhibition by SRP was not detected and only barely
detectable amounts of glycosylation were observed. Thus , the hydrophobic fusion
domain in its natural context is not recognized by SRP and does not direct
significant amounts of membrane insertion. Therefore, these two mutants are
depicted as cytoplasmic proteins in Figure 10.
A recent study replaced the signal/anchor domain of the influenza NA
protein with the hydrophobic fusion peptide of a paramyxovirus , SV 5 (Paterson
and Lamb , 1990). Cellular expression of the resulting NAF construct resulted in a
molecule which was translocated and cleaved by signal peptidase. The 
construct described here has the fusion domain similarily positioned near the
rnino terminus and results in translocation in vitro but at an exceedingly 
low
fficiency. It is possible that a cellular component assisted the transloction of the
AF protein and this component is lacking in the cell-free system. It is also
ossible that membrane targeting of the NAF protein was assisted by the NA
sequences flanking the fusion sequence. It has been previously shown that the
rnino terminal flanking region of the NDV HN protein is very important in efficient
and proper membrane insertion (Wilson et aI. , 1990). Substitution of two basic
amino acids preceding the hydrophobic signal of cytochrome P450 reversed the
M0rmal topology of the 
protein (Szczesna et al. 1989). Also , it appears that the
J;ydrophobic sequences within type II glycoproteins do not specifically direct
:i\i(
translocation. Zerial et aI. , (1987) has found that several hydrophobic sequences
;;can replace the signal/anchor of a type II glycoprotein , the transferrin receptor, and
:,:t'
):: , .
\stil maintain its ability to be translocated. Consequently, the absence of
;;;.
' 0
,:.':;.
;,! translocation of the MF construct may be due to an inability of the flanking
.; "
equences to promote translocation.
The second and third hydrophobic domains of the NDV fusion protein
sequence resemble stop transfer/membrane anchor sequences. Results of
protease digestion of the cell free products support the notion that the third
hydrophobic domain near the carboxy terminus has stop transfer activity.
Following translocation , protease digestion resulted in species of F and SF
proteins only slightly reduced in size. The exposed protease sensitive region was
shown to be the carboxy terminus by digesting translocated truncated forms of the
protein that lacked the third hydrophobic segment. The slower migrating, fully
glycosylated, products of the dC91 and SFdC91 messages were completely
f)rotected from protease.
The SF mRNA-directed reactions have consistently been observed to
contain a higher percentage of glycosylated product than was seen with the F
protein. One possible explanation for this discrepancy is that the less hydrophobic
. SF-molecules are more easily glycosylated 
than the fusion protein. However, a
PQPulation of only partially translocated fusion molecules would also reduce the
Ln amount of fully glycosylated species produced by the F mRNA relative to the SF
mANA. It therefore seems probable that the wild type F protein may be associated
- n
With - membranes in two different ways in the cell free system and that the fusion
- sequence may function as a weak stop transfer signal as depicted as form 2 in
gure 10. This result would be consistent with results from Kretzschmar et al
y (1992) who found that the fusion peptide of an influenza HA molecule could serve
)Y::J"
\. '
:;8.5 a membrane anchor under certain conditions.
. / . .'\,
Examination of the protease protected fragments derived from the F and
'dC91 proteins again suggested that a second population of molecules exist which
!!iJ' are only partially translocated and may be anchored in the membrane by the
; !
;'l i$econd hydrophobic domain , the fusion peptide. Translation of the dC91 mRNA in
::' 
f.;:(the presence of membranes and SRP resulted in a translation product with a
':'
:YG1, Ji.
;: '
itfM' mobilty that is expected to result from processing by the signal peptidase and
~~~;\ ,,:;::.;;; ,
;Iacking glycosylation as seen dotted in Figure 7 , lane 2. Proteinase K digestion
' .
vealed that this population of unglycosylated, but cleaved dC91 molecules are
):' ;\-
"tf:
:)':I sceptible to digestion and, consequently, must be only partially translocated.
: ;/
urther, if this unglycosylated product was anchored by the fusion domain, the
:: . ' \ -
Z,;;fragment protected from proteinase K would be predicted to have approximately
, .
I;'
' ,
23 amino acids, and have a molecular weight of about 16 kDa after glycosylation.
i?,:,
lndeed , a fragment with approximately that mobilty was consistently produced by
:f!j:,
igestion of the For dC91 proteins (Figure 5, lane 4 , Figure 6, lane 5, and Figure 7,
;!i:(;"
)-;+";
ne 3 , Figure 8, lane 4). From a calibration curve derived from the migration of
rnolecular weight proteins in gels, this fragment migrated as a 21 kDa species. 
contrast, digestion of the SFdC91 protein, which is missing both the fusion
:sequence and carboxy-
terminus , showed a small population of unglycosylated,
1i1
releaved species that 
was protected and evidently fully translocated into the lumen
f the vesicle (Figure 7, lanes 6 and 7). No 21 kDa species was produced
tollowing digestion of the SF or SFdC91 proteins, proteins missing the fusion
Analysis of the Fg mutant verified the existence of the two topological forms
ji.
: bf the fusion protein. This mutant was constructed to "tag" the protected fragment
with an additional glycosylation site. 
Protease digestion of the translocated Fg
::t
mutant indicated that the protected fragment was from the amino terminus of the
protein.
The 21 kD protected species is 5 kD larger, or roughly, 50 residues longer
than predicted. The 50 residues following the fusion peptide (129-182) consist of
, a heptad repeat and have been predicted to form an alpha helical structure with an
, apolar face (Figure 21; Lamb, 1993)). A comparably placed alpha helix of the
. influenza HA monomer has been predicted to be associated with the membrane
Ik prior to oligomerization (Gething, 1986) Thus, the NDV alpha helix may be part of
);\5ii
Ys4tYi 
the protease-resistant 21 kD fragment protected in the cell-free assays. Complete
:t;-1( .
jrif:digestion of the 21 kD fragment in the presence of detergents suggested that it was
f,f;
, associated with the membrane and inaccessible to the protease. Similar results
;'-'
;r;
were obtained from studying the HIV env protein in a cell-free system and revealed
hat gp160 had a potential alpha helical domain near the C-terminus that
ssociated with the membrane surface (Haffar, 1988). A deletion mutant was
?:c
, ' .
:'1;': : designed to determine if this potential helical structure was associated with the
Preliminary results have indicated that the residues within the potential
helix are protease resistant due to a membrane association (not shown).
Studies of protein translocation have identified other proteins that can adopt
, -
re than one topology during biosynthesis in cell-free systems (Garcia et aI.
le88). A striking example is the scrapie prion protein that was shown to be present
... !. .
; in both a membrane integrated, and fully translocated form after cell-free
biOsynthesis (Lopez et al. , 1990).
. !!
(ii)j.
';, , .
The context in which a hydrophobic domain resides appears to be crucial to
JB, he topological function. Previous reports suggested that the fusion domain is on
' the threshold of hydrophobicity required to arrest translocation (Paterson and
!f Lamb, 1987) but passes this threshold and is able to halt translocation when
~~~
i;: located' at the carboxy end of a molecule. When placed near the amino terminus
",,-~~~
s in the NAF construct , a fusion peptide functioned as a cleavable signal
T:* sequence in vivo (Paterson and Lamb , 1990). These studies suggest that the
nB:;'
: ,. (
Fnregions flanking the fusion domain in the nascent fusion protein may contribute to
. - .:,./, :):' .
the inefficient anchoring ability. This behavior may not be restricted to the
. :~ ~ ~? - ) .
ib"hydrophobic fusion peptide , as alteration of the sequence upstream of the first
:1'
/' transmembrane region of the prion protein allows translocation of the downstream
" h
hydrophobic domain (Yost et aI. , 1990).
: ": .
The wheat-germ translation system has been useful in faithfully synthesizing
everal viral fusion glycoproteins (Haffar, 1988; Chao, 1987). Curiously, these
studies have not reported the ability of a hydrophobic fusion domain to halt
, troanslocation. It is not known whether this descepancy is due to a difference in
:fusion proteins or a difference in methods. As the microsomal membranes and
;iCWheat germ extract are independently prepared, it seems possible that the
)\;
mponents necessary for faithful translocation may vary with the laboratory. 
test this idea, the protease protection assay was performed following translocation
of F in a rabbit reticulocyte extract as described in Materials and Methods. Results
- from this experiment were identical to those obtained with the wheat germ system
(not shown), suggesting that the transcription and translation components do not
account for the differing topologies. Alternatively, the preparation of the salt-
washed membranes may vary between laboratories. Nichhitta and coworkers have
shown that partial translocation of the prolactin precursor can occur when the KCI
concentration is not between 0.4- 7 M during preparation of the membranes
(1990) and the net transfer of a nascent protein does not occur in the absence of
lumenal proteins (1993).
When the dC91 and wild type fusion proteins were expressed in Cos cells
the molecules detected by immunoprecipitation migrated consistent with fully
glycosylated molecules, suggesting complete membrane translocation. This result
was not comparable with the results obtained from the cell-free system. As the
monoclonal antibody used for these assays was generated against mature
, virion F
protein , it was likely that it would not detect underglycosylated molecules. In an
effort to generate new anti-F sera , fragments of the F protein were synthesized in
bacteria using the pATH vectors as described in Materials and Methods. This
unglycosylated protein was used to generate polyclonal antisera in rabbits. Three
different antiseras were tested. None of the three antibodies were able to detect a
partially translocated form of the fusion protein expresssed in Cos cells. This
suggested that the inabiliy to detect unglycosylated forms of cellular dC91 or the
wild type protein is not due to inadequacies of the antisera used for
immunoprecipitations.
An additional piece of evidence that supports the notion of one topological
form of the cellular fusion protein
, comes through the use of a mutant protein which
, "
does not become cleaved during cellular transport. When this F117L mutant was
expressed in Cos cells and subjected to western blot analysis , only one species
was detected under both reducing and nonreducing conditions. Under the
conditions used for the analysis, all forms of the molecules should have been
. detected. However, these results do not rule out the possiblity that partially
translocated , underglycosylated fusion proteins are unstable or quickly degraded
in vivo.
The topological forms of the fusion proteins detected in the cell-free system
may reveal a novel intermediate form of the fusion protein that is undetectable with
in vivo expression systems. Chuck and Lingappa have recently described a
specific pause transfer sequence contained within apolipoprotein B , a ligand for
the low density lipoprotein receptor (1993). This sequence mediates discrete
pauses in the translocation of the protein and can confer translocational pausing to
an otherwise secretory chimeric protein (Chuck and Lingappa , 1992). Further
translocation was found to restart post-translation ally. Generally, protein
translocation can occur following translation (Schatz , 1986; Perara , 1986).
However, as shown by Coller et ai , (1988) precursor proteins must be unfolded in
order for translocation to occur post-translation ally in E. coli and SecB may assist in
this unfolding. Furthermore , it seems likely that the partially translocated fusion
protein species may represent a population of molecules in which translocation
has paused , possibly due to the hydrophobic fusion sequence , and been unable to
resume. It would follow that the C-terminal regions of the protein may prematurely
fold and , unlike lipoprotein B , inhibit further translocation. Consequently, the
topological forms of the fusion protein detected by the in vitro system may represent
a translocation intermediate. Some feature of cellular translocation makes this
intermediate form undetectable.
, .
If the discrepancies in protein topology found between the cell-free and
cellular expression systems are due to a translocational pause that causes the
protein to become trapped during in vitro translocation , then it may be that
additional cellular processes or cytosolic factors , such as the SecB of E. coli , are
required to allow proper translocation. The system described in this work may be
useful to test the translocation-promotion potential of cellular factors. In addition
the requirement for unfolding may be tested by the addition of mild denaturants or
cellular "unfoldases. 
In summary, in a cell-free system , the fusion protein can adopt two different
topologies with respect to membranes. In one population , translocation results in
cleavage of the signal sequence and continues until a stop-transfer sequence is
reached near the carboxy terminus. The second hydrophobic region , the fusion
sequence, of the fusion protein appears to be translocated. However, in a second
population this fusion domain may act as the stop transfer sequence resulting in a
protein anchored by the fusion sequence. Although the fusion domain has
characteristics similar to type II signal/anchor sequences , when placed near the
amino terminus of a protein it has little ability to direct translocation.
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Figure 1. Construction of full-length fusion gene.
(A) The overlapping clones pTL 831 and 438 were derived as previously
described (McGinnes et a\., 1986) and cloned into pBR322. The 5' sequence of the
fusion protein contained within the Pvul and Xmal sites of pTL831 was excised and
ligated to the Pvul-Xmal fragment from pTL438 containing the 3' region of the
fusion gene (described in Materials and Methods). Ligation of the two fragments
using the common Xma I site, resulted in clone pTLF which contains the entire
coding region for the fusion gene. Circles represent vector plasm ids. Legend to
, Figure 1 B defines the notation for restriction enzymes.
(B) Removal of G-C tails at ends of the fusion gene and assembly of the full-
length gene in pSP64. From the plasmid pTLF, the 52-bp BamHI-BamHI , the 1545-
bp BamHI-Sphl , and the 97-bp Sphl-Mnl1 fragments were ligated into the BamHI
, and Smal sites of the cloning cassette of pSP64 as described in Materials and
Methods to produce pSP6Fst. P , Pstl; X , Xmal; B , BamHI; Sph , Sphl; H , HindUI; S,
Sail; Sm , Smal; E, EcoRI.
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Figure 2. Schematic diagram of precursor form of wild-type and mutant fusion
proteins. Panel A. Relative positions of restriction enzyme sites in pSP6Fst used
for construction of mutant genes. Ps, Pstl; B , BamHI; Pv, Pvull; Hf, Hinfl. Panel B.
Schematic diagram of protein structures predicted from amino acid sequence of the
wild type and mutant fusion protein genes. Vertical bars on wild-type indicate
methionine codons used for translation initiation of F13 and FSS. Filed boxes
represent the relative position of the hydrophobic domains (signal , fusion and
anchor sequences, respectively) of the fusion and mutant proteins. X's represent
positions of potential glycosylation sites. Construction of plasm ids is described in
Materials and Methods. The MF gene results from deletion of the sequences 5' to
the Hinfl site of pSP6Fst followed by insertion of a methione codon from the NDV
matrix protein cDNA. The fusion peptide was deleted from the F gene by removal
of sequences between the two Pvull sites to produce the SF cDNA. The sequence
for the membrane anchor was removed from the fusion and SF cDNAs by deletion
of sequences between the EcoRV and Sphl sites. Ligation of the two blunt ends
produced a translational frame-shift resulting in a termination site. Vertical arrows
Identify cleavage sites described in the text.
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Figure 3. In vitro expression of proteins in the presence and absence of SRP.
In vitro synthesized transcripts were used to direct protein synthesis in a
wheat germ extract and are indicated above their respective lanes. Products are
synthesized, labelled with (35S)-methionine, and electrophoresed under reducing
conditions as described in Materials and Methods. Lane 1 , no added mRNA; lanes
2 and 3, F mRNA; lanes 4 and 5 , F13 mRNA; lanes 6 and 7 , FSS mRNA; lanes 8
and 9, MF mRNA; lanes 9 and 10, SF mRNA. Lanes 2-13 contain mRNA for the
NDV matrix protein to control for nonspecific inhibition of the SRP preparation.
Lanes 3, 5, 7 , 9 , 11 ,and 13 contain SRP; all other lanes were supplemented with
SRP buffer.
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Figure 4. Translocation in the presence of membranes , SRP , and NYT.
The mRNAs used to direct cell-free protein synthesis are indicated. Lanes 1-
, F mRNA; lanes 5-8, F13 mRNA; lanes 9- , FSS mRNA; lanes 13-16, SF mRNA;
lanes 17- , MF mRNA. Translation reactions were supplemented with
components as indicated above each lane. Salt-washed microsomal membranes
are indicated as KRM. The tripeptide NYT was added during the reaction at a final
concentration of 400 J.M to inhibit glycosylation.
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Figure 5. Protease digestion of proteins synthesized in vivo and in cell-free
reactions.
Wheat germ translation reactions were programmed with mRNA for the F
protein in lanes 1-5 and mRNA for the SF protein , which is missing the fusion
domain , in lanes 9-12. RM indicates the addition of membranes and SRP to the
reaction. Lanes 6-8 are products from isolated vesicles from NDV infected chick
embryo cells labelled with (35S)methionine for 5 minutes. Proteinase K, used at 20
1l9/ml for 60 minutes at 4 C, and Triton X-100, used at 0.5%, were added following
the translation reaction as indicated above each lane. The fusion protein
synthesized in infected cell extracts is indicated by the dot in lane 6. Reference to
the protected fragment indicated by a dot in lane 4 is found in the text.
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Figure 6. Membrane integrity during proteinase K digestion.
The fusion and SF proteins were synthesized along with the bovine
secretory protein preprolactin. Lanes 1-5 contained mRNA for the fusion protein.
Lanes 3-10 contained mRNA for preprolactin. Lanes 8- 12 result from reactions
programmed with mRNA for the SF protein. Translation of the F and SF mRNA
proceeded for 90 minutes. Total pituitary RNA, containing preprolactin mRNA , was
added to the reaction for the final 30 (lane 3) or 60 minutes (lanes 4-10). 
indicates the addition of a microsomal membrane preparation containing SRP.
Proteinase K concentration was 20 J.g/ml and Triton X- 100 was used at a final
concentration of 0.5%. Reference to the dot by the low molecular weight protected
fragment in lane 5 is found in the text.
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Figure 7. Translocation and proteinase K digestion of the truncated F and SF
proteins.
The wheat germ translation reaction shown in lanes 1-4 contained mRNA for
the dC91 protein; lanes 5-8 contained SFdC91 mRNA. Membrane additions,
proteinase K and detergent treatments are shown above each lane and added as
described in Figure 5. The species indicated by dots in lanes 2 and 3 are
discussed in the text.
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Figure 8. Protease Protection analysis of Fg mutant.
Transcription- linked wheat germ translation reactions were programmed
with mRNA for the fusion protein in lanes 1-7 and mRNA for the Fg protein in lanes
13. The reactions were supplemented with components as indicated above each
lane. NYT, detergent , and proteinase K were added as described in previous
figure legends. The approximate molecular weight of the smaller membrane-
protected species , identified as 21 and 17 kD , were estimated from the
electrophoretic migration of molecular weight protein markers (not shown).
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Figure 9. In vivo expression of the wild type and truncated fusion proteins.
Cos cells transiently transfected with either the dC91-pSVL (lanes 1-12), F-
pSVL (lanes 13-17) or parental vector pSVL (lanes 18-20) were lysed in RSB
Triton-X 100 and deoxycholate as described under Materials and Methods. Cells
were radioactively pulse- labelled for 30 minutes (lanes P; 6, 13 and 18) or chased
with cold methionine for 1 , 2 or 3 hours as indicated above each lane. Celllysates
(lanes C) or culture supernatents (lanes S) were immunoprecipitated with a
monoclonal antibody directed against F (Fu1a) and resolved in the absence (lanes
1-3) or presence of B-mercaptoethanol (lanes 6-20). The dots indicate the
position of the uncleaved, glycosylated, precursor form of dC91 and F.
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Figure 10. Schematic of the topology of fusion and mutant proteins synthesized in
the presence of microsomal membranes.
Hydrophobic domains are indicated as described in Figure 2; C, carboxy
terminus; N , amino terminus; * , potential glycosylation sites; dotted region
represents the fusion peptide; horizontal marks indicate the anchor; vertical marks
indicate the signal sequence. Positioning of carbohydrates and cleaved signal
sequences is for illustrational purposes only. The SF protein and form 1 of the wild
type fusion protein , F , behave like class I glycoproteins. The amino terminus is
inserted into the membrane , the signal sequence is cleaved , translocation
continues until a stop-transfer sequence is reached near the carboxy terminus and
exposing part of the molecule. In form 1 of the anchorless protein , dC91 , no part of
the molecule is exposed. A portion of the F and dC91 molecules , molecules
containing the hydrophobic fusion sequence, are partially translocated as indicated
by forms 2. They may undergo signal sequence cleavage and, except for
approximately 21 kD , a majority of the molecule is exposed on the cytoplasmic side
of membranes. In the absence of the complete signal sequence, the fusion domain
cannot target a nascent chain to membranes as indicated by the untranslocated
FSS and MF proteins.
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Table I. SRP-Mediated Reduction of Protein Synthesis.
Experiment Experiment 2
SRp SRp Average
% Red. % Red. % Reduction
1.41 62.4 72.4 67.4
F13 1.49 1.40
FSS 1.01 18. 10.
1.42 11.
1.66 0.49 70. 81. 75.
Table I. Protein synthesis was quantitated from a Betascope scan of (35S)- labelled
products. The cpm of full- length protducts was normalized to that of the matrix
protein synthesized in each reaction.
a SRP was added to the translation reaction as indicated in legend to Figure 3.
The percent decrease in protein synthesis due to inhibition by SRP was
determined by using the following calculation: % Reduction = 1 - (normalized cpm
from the F protein synthesized in the presence of SRP/ normalized cpm from F
protein synthesized in absence of SRP). The gel shown in Figure 3 corresponds to
experiment 2.
CHAPTER IV
AN ANALYSIS OF STRUCTURAL AND FUNCTIONAL DOMAINS
INTRODUCTION
Fusion between a viral membrane and a target cell membrane is an
essential step in the infectivity of the Paramyxoviruses. The membrane of the
Newcastle disease virus (NDV) contains spike structures made up of two types of
glycoproteins which faciltate this process, the hemagglutinin-neuraminidase (HN)
and fusion glycoproteins. The HN glycoprotein is responsible for attaching the
virion to the target cell , whereas the fusion glycoprotein is believed to disrupt the
target cell membrane and induce membrane fusion (reviewed in Morrison and
Portner, 1991). The fusion protein monomer is synthesized as a precursor
denoted FO. It is inserted into the rough endoplasmic reticulum membrane (RER
revieVVed by Lingappa , 1989) and cotranslationally glycosylated as a precursor.
Following exit from the RER , the fusion protein is cleaved during transport
through the Golgi apparatus into two disulfide- linked subunits , F1 and F2. This
processing exposses the hydrophobic domain at the amino terminus of the 
subunit and is essential for the biological activity of the mature protein (Scheid
and Choppin , 1974). This hydrophobic domain is highly conserved among
paramyxovirus fusion proteins and is considered to be directly involved in
mediating membrane fusion (White , 1990; Morrison and Portner, 1991). All the
paramyxovirus fusion proteins are type I glycoproteins that have one hydrophobic
transmembrane region near the carboxy terminus of the F 1 subunit which
functions to anchor the protein in the bilayer.
An examination of the primary sequence of the fusion protein revealed
general structural features of the protein. A comparative analysis of the fusion
protei sequences within the family of paramyxoviruses substantiated this
information by revealing areas of conservation that may identify core regions of
the protein pertinant to the fusogenic structure of the NDV molecule.
A Garnier-Robson structural prediction of the primary sequence has
identified several regions within the fusion protein that have the potential to form
alpha helices. The longest potential helix (Garnier et ai , 1978) of the NDV fusion
protein lies adjacent to the hydrophobic fusion peptide at the amino terminus of
F1 and involves residues 129-180. When the amino acid sequence of this region
is displayed on an ideal alpha-helical wheel , the charged residues line up on one
face of the helix, while a hydrophobic face is created on the opposing side of the
helix. Mutations introduced into this helix often result in proteins that are either
unable to induce fusion or not transported to the cell surface (Wang et ai , 1992
Sergei et ai , 1994). Since misfolded surface proteins are often retained in the ER
(Segel , 1992), this helix in the fusion protein may be important for the proper
folding of the molecule.
A second potential alpha helical domain lies immediately upstream of the
transmembrane region and includes residues 476-491. This sequence consists
of a series of highly conserved leucine or isoleucine residues which occur at
every seventh residue (Figure 11) and was first described by Buckland and Wild
(1989). When the amino acid sequence of this region from the NDV fusion
protein is displayed on an ideal alpha-helical wheel , the periodic repeat of leucine
or isoleucine residues line up on one face of the helix for 6 helical turns (Figure
12). All the charged residues face opposing sides of the helix. This type of
leucine repeat within an alpha helix has been identified in several DNA binding
proteins and has been termed the leucine zipper motif (Landshultz 1988). This
type of alpha helix has been proposed to associate proteins by coiling around
each other and contact along the hydrophobic faces, resulting in a coiled-coil
structure (O'Shea , 1989). The potential to form a coiled-coil predicts that this
leucine region of the fusion protein may be involved in the oligomerization of the
molecule. The oligomeric structure of the mature form of the NDV fusion protein
has recently been suggested to be a trimer by cross- linking studies (Russell et ai
1994) .
The leucine zipper helix is of interest for two reason. First, several reports
suggest that the zipper motif of fusogenic proteins is necessary for infectivity and
syncytium formation of enveloped viruses (Buckland , 1992; Chen 1993). As this
domain is expected to be far removed from the site of fusion on a target cell
information leading to the function of this domain wil assist in elucidating the
mechanism of the fusion process. Also , as previously suggested , the leucine
motif has properties similar to that of other proteins known to form coiled-coil
structures , and this motif may maintain an oligomeric form of the protein that is
necessary for membrane fusion.
In order to define the requirements for the leucine residues in this motif for
the structure and biological activity of the NDV fusion protein , three of the highly
conserved residues were each replaced by an alanine. The wild-type and mutant
F DNAs were expressed from an SV40-based vector in Cos-7 cells and tested for
fusion activity. Although single leucine-alanine substitutions did not significantly
affect the fusion activity, substitution of two or three leucines abolished the ability
to cause syncytium formation. In contrast , nonconservative substitutions on polar
sides of the potential helix did not significantly affect the fusion activity.
Molecular weight estimations using centrifugation through sucrose gradients
indicated that the leucine mutants retained the abilty to oligomerize. Deletion
mutations were generated to demonstrate the requirement for the entire helix and
for the carboxy terminal hydrophobic domain for stability of this oligomer. 
proteins produced from these deletion mutants were detected extracellularly in an
oligomeric form. A model is presented which suggests that fusion activity
requires the conserved leucine residues to interact with and disorganize the
infected cell membrane.
, ,
RESUL TS
Muta enesis of he tadic leucines. The amino acid sequence of the NDV
fusion protein in the region of the leucine zipper motif is shown in Figure 13. 
investigate the structural and functional role of the conserved leucines, the third,
fourth, or fifth repetitive leucine (L3, L4 , L5, respectively) at residues 481 488,
and 495 respectvely, were changed to alanine. Mutations were introduced singly
and in several combinations as indicated in Figure 13. The location of mutations
on the predicted helix is shown in Figure 12. In order to allow an examination of
the function of the leucines and not the potential helical structure , alanine was
chosen for the substitutions.
ression of mutants. To characterize these mutant proteins, the
mutated fusion cDNAs were subcloned from M13mp18 into the SV-40 based
expression vector, pSVL. This vector allows transient expression in cells that
express the large T-antigen. Cos 7 cells were transfected using a DEAE-dextran
protocol described in Materials and Methods. At 48 hours post-transfection
proteins in the post-nuclear extracts were separated on a non reducing gel and
subjected to western analysis. Western blots were probed with a rabbit antibody
generated against 29 residues at the C-terminus of the F protein (Wang et ai
1992). The extract from cells transfected with only the pSVL vector was included
to control for nonspecific antisera binding (Figure 14 , lane 1). The extract from
cells expressing the wild-type protein resulted in one novel band (lane 2).
Expression of all the mutant DNAs resulted in products that migrated with the
wild-type protein , at amounts similar to wild type. Curiously, the proteins that
have the L3A mutation ran slower than the wild-type protein (lanes 3, 9).
This decreased mobility was also seen in the presence of reducing agents and
when the L3A mRNA was translated in a cell-free system in the absence of
membranes and in the presence of reducing agent , indicating it was not due to
differential glycosylation or alterations in intramolecular disulfide bonds (not
shown). In addition , all fusion proteins resulted in minor species of lower
mobilty.
Mutations in viral glycoproteins may result in proteins which are improperly
folded. To examine the effect these mutations may have on the folding of the
molecule, the panel of mutants was subjected to a two hour pulse label and
immunoprecipitated with a monoclonal antibody directed against the virion fusion
protein. This Fu1a antibody has been shown to bind only relatively mature
antigen (Morrison et ai , 1987). Figure 15 shows that the antibody precipitated all
the mutant fusion proteins in approximately equivalent amounts. This result
suggested that the folding of the mutant molecules is not significantly different
from that of the wild-type protein.
Surface expression of wild-type and mutants. For the fusion protein to be
functional , it must be transported through the cell and properly expressed at the
cell surface. When the surface expression of the proteins was evaluated by
immunoflouresence , all proteins were expressed on the cell surface (not shown).
To further examine the surface expression , an assay designed to quantitate
surface expression of an antigen was employed (Morrison et ai , 1990). The
transfected cells were labeled with (35S)-methionine and chased with cold
methionine to allow the labelled proteins to accumulate at the cell surface. The
intact cells were incubated with a polyclonal antibody generated against virion
protein. After an incubation on ice the unbound antibody was removed by
thoroughly washing the plates in ice-cold PBS. The cells were lysed in 1 % Triton
and 0.5% sodium deoxycholate. The immune complexes were precipitated with
beads conjugated to anti-rabbit IgG. The cell surface proteins were
electrophoresed under nonreducing conditions. To control for any precipitation of
intracellular F protein, unlabelled F-expressing cells were incubated with the
primary antibody, washed, and the lysate was combined with a cell lysate from
labelled, unprobed F-expressing cells. The results from this assay are shown in
Figure 16A and indicated that all mutant fusion proteins were expressed at the
cell surface.
The autoradiogram from this experiment and two other comparable
experiments were scanned with a microdensitometer to quantitate the amount of
protein immunoprecipitated. The averages of the results obtained, expressed as
the percentage of wild-type protein , are: WT =100, L3A=147; L4A=84; L5A=83;
L34A=240; L35A=246; L45A=131; L345A=280.
Precursor rocessin . For the mutant fusion proteins to have biological
activity, the precursor must become cleaved and the disulfide-linked F1 and F2
subunits must exist at the surface (Scheid and Choppin , 1977). To evaluate the
form of the proteins at the cell surface , the precipitated proteins were
electrophoresed in the presence of reducing agent. Under these conditions, the
subunits should dissociate, and the F1 subunit should be detected. The results
shown in Figure 16B indicated that all proteins become cleaved and result in the
faster migrating F 1 species. In all cases, precursor cleavage appears to be
inefficient as the uncleaved precursor species is also detected at the cell surface.
Fusion abilit with sin le leucine mutations. Since all six mutant fusion
glycoproteins were expressed at the cell surface, the biological function of the
proteins was assessed. To determine whether these conserved leucines are
required for the fusion activity of the NDV fusion protein , cells expressing the
proteins were subjected to a fusion assay. In this assay, the fusion and HN
cDNAs are cotransfected into subconfluent Cos cells. During optimization of this
assay, the use of Lipofectin (Gibco) was determined to give preferential results
over the DEAE-dextran protocol which required harsher incubation conditions
(not shown). When the wild-type HN and F proteins are co-expressed , multi-
nucleated giant cells form within 24 hours and the size of syncytia increases
linearly with time for over 72 hours (Figure 17). To quantitate this activity, the
plates were scanned for fusion and the number of nuclei in forty syncytia were
counted at 24 , 48 and 72 hours post transfection for each sample. Each protein
in question was assayed three times and the resulting values were averaged.
Cos cells show background fusion at low frequency with an average of 3-4 nuclei
per syncytia. This background value is also obtained from cells transfected with
only the parental vector and was subtracted from each assay.
To define the requirements for the individual leucine residues for the
process of fusion, the activities of mutants L3A , L4A and L5A were determined.
When any of these mutant proteins were expressed alone , they had near
background levels of fusion, again demonstrating the requirement for the
presence of the HN protein (not shown). As shown in Figure 18, when these
mutant fusion proteins were co-expressed with HN , all showed fusion activity.
Curiously, there appeared to be a gradient effect on the fusion activity with
changes from the third to fifth leucine. Although the fifth leucine is least
conserved among the other paramyxovirus fusion proteins, substitution of this
leucine resulted in the most disruption of the syncytia-forming ability of any of the
single substitutions. Although the three mutants showed a slight decrease in
fusion activity, these results suggested that a single leucine substitution does not
significantly alter the fusion ability of the protein.
Fusion activity of proteins with multiple leucine substitutions. To test
further the requirement of the conserved leucines for the biological function of the
protein , the double and triple leucine mutants were cotransfected with HN cDNA
, . .' .
Results are shown in Figure 19. When two or more of the conserved leucines
were changed, the ability of the protein to induce fusion was abolished. These
results suggested that the lindividual eucines do not have importance but that the
fusion activity of the protein depends on repetitive leucines.
The S473A. E482K. and N485K mutants. The lack of fusion activity of
, proteins with multiple leucine substitutions indicated that this region of the fusion
protein is required for its biological activity. To assess further the sensitivity of
this region to mutations , three nonconservative substitutions were introduced into
the polar face of the potential helix. The asparagine at position 485 , which falls
between leucines 3 and 4 , is predicted to be on a polar face of the alpha-helix as
shown in Figure 12. This residue was changed to a basic residue , lysine , to
create the N485K mutant. The predicted alpha helix has acidic residues in the b
positions on the helix. To alter this region , a basic residue replaced the acidic
glutamine at residue 482 to produce the E482K mutant. An additional mutant
was created to test the functional requirements of the partially conserved N-
linked glycosylation consensus site that falls between the first and second
heptadic leucine residues (Figures 12 and 13). This mutant , S473A, abolished
the potential for glycosylation of the asparagine at position 471 by replacing the
polar serine residue with the nonpolar alanine residue.
The expression of these three mutant genes was examined by Western
analysis. The E482K and N485K proteins had an electrophoretic mobility similar
to that of the wild-type protein (Figure 20). The S473A protein had a slight
increase in mobility as compared to the wild type protein , suggesting that the N-
linked glycosylation site at residue 471 is normally used. In addition , the three
mutants were found to be present at the cell surface when the surface antigens
were immunoprecipitated as described above (Figure 16). Quantitation of the
surface expression, relative to the wild-type are: S473A=92%, E482K=31% and
N485K=68%.
When the N485K, E482K and S473A mutants were subjected to the fusion
assay, all mutants had fusion activity, as shown in Figure 21. While levels are
reduced from wild type , none of the mutations abolished fusion to the extent of
the double or triple leucine mutations. These results, along with the finding that
the fusion activity is abolished only by multiple leucine substitutions, suggested
that only the nonpolar side of the helix involving the conserved leucine residues
is specifically required for the function of the protein. Single substitutions along
the hydrophobic face or alterations that disrupt the charge distribution or
glycosylation on other sides of the potential helix do not appear to affect
significantly the biological activity.
Expression of HN in the presence of F mutants . For cell fusion to occur
both the HN and F glycoproteins must be expressed at the surface of the cell.
The mutants unable to induce fusion may alter the cellular transport or
expression of HN and the absence of fusion activity might be due to an absence
of the HN protein at the cell surface. To establish the co-expression of HN and
the mutant fusion proteins at the surface of the cell , dual immunoflouresence was
employed. This examination revealed that HN was expressed in all cases , but at
much lower levels than when expressed alone (not shown). This apparent
decrease in HN expression following co-expression was confirmed by
immunoprecipitating the cell surface antigens as previously described. However
the decrease in detection of HN expression was comparable between the wild-
type and mutant fusion proteins indicating that there was not a selective lack of
HN protein with the multiple leucine mutants (not shown).
Oligomer Formation. The lack of fusion activity for the multiple leucine
mutants could not be accounted for by any obvious defect in the processing,
steady-state level , or cell surface expression of the mutant fusion proteins. Since
the leucine zipper motif has been implicated in the oligomerization of proteins
(O' Shea et ai, 1992), it follows that the leucine mutants might be defective in
fusion activity because of faulty oligomerization.
To examine the oligomeric structure of the wild-type fusion protein
sucrose gradients were employed. Cos cells expressing the F protein were lysed
in a low salt buffer containing a non- ionic detergent (1% Triton-X 100).
lodoacetamide was added (10 mM) to block any free sulfhydryl groups from
forming aberrant disulfide bonds during lysis. The post-nuclear extract was
fractionated on an 10-25% linear sucrose gradient. This gradient was optimized
to separate proteins in the 60-300 kD range. To reduce pelleting of larger
species, a 2M sucrose pad was positioned at the bottom of the gradient. Twenty-
one 0.5 ml fractions were collected from the top of the tube , TCA precipitated,
solubilized and subjected to western blot analysis. Molecular weight markers
were used to calibrate the gradient and indicated that an ideal monomer, dimer
trimer and tetramer of F would sediment in fractions 15, 11 , 7, and 2
respectively. However, the molecular weight positions were only intended to
serve as a reference point for the oligomeric structure of the fusion protein, which
sedimented in fractions 8-10 at approximately 190 kDa (Figure 22A). Very little
protein sedimented in the monomer region or towards the bottom of the gradient.
To examine the stability of this oligomer, a lysate of Cos cells expressing
the F protein was supplemented with either 0.5% sodium deoxycholate or 5%
SDS prior to centrifugation. Sodium deoxycholate had no effect on the
sedimentation pattern of the protein , whereas a majority of the protein
dissociated into a monomer and sedimented in fractions 14- 16 in the presence of
SDS (not shown). This result indicated that the mature F protein expressed in
Cos cells forms a Triton X-100 insensitive oligomeric structure that can be
disrupted by solubilization in SDS and, as expected , is not covalently associated.
To examine the oligomeric structure of the triple leucine mutant , cells
expressing the L345A mutant were similarily lysed and fractionated on a sucrose
gradient. As shown in Figure 22B , this protein formed a Triton X-100-insensitive
structure that sedimented similarly to that of the wild-type protein. Again , very
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little protein sedimented in the monomer region or pellet. Thus the conserved
leucines are not required for the maintenance of the Triton X-100-insensitive
oligomeric structure of the fusion protein. Furthermore , the lack of biological
activity of the multiple leucine mutant cannot simply be accounted for by the
leucine zipper and its possible contributions to disruption of this apparent
oligomeric structure.
Molecular domain requirements for oligomerization . Given this finding, an
attempt was made to identify the region of the protein that is responsible for the
oligomerization. The NDV fusion protein has two potential amphipathic alpha
helices (AAH) that could be involved in the oligomeric structure. The first
potential AAH on the F 1 subunit encompasses the sequence immediately
downstream from the fusion peptide. As the previous results indicated , the
leucine zipper region is not required for the maintenance of the oligomeric
structure of the protein , and it seemed possible that the first helix may assist in
the formation of the oligomeric structure. To test this hypothesis , two mutants in
this region were added to the triple leucine mutant. The K155L mutation
removes a charge from one face , whereas the A 140K substitution adds a
charged residue to a hydrophobic face of the predicted helix (Figure 23). These
subsitutions produced the K155UL345A and A 140K/L345A mutants,
respectively. Since these mutant proteins had both potential amphipathic helices
altered , it was expected that they might sediment as monomers when
fractionated on a gradient. Surprisingly, that was not the case as is apparent
from Figure 24. The K155L mutant protein was inefficiently processed and
resulted in sedimentation of the protein towards the bottom of the gradient (Panel
B). The addition of the A 140K mutation did not seem to significantly disrupt the
oligomeric structure of the wild-type (not shown) or the L345A mutant as shown
in Figure 24A. These results suggested that the oligomeric structure of the F
protein is stable after the introduction of nonconservative mutations into the first
potential alpha helical region.
To further delineate the region responsible for oligomerization , a
termination codon was inserted immediately upstream of the coding sequence for
the transmembrane region. This deletion removed the cytoplasmic tail and the
transmembrane region while retaining the leucine zipper (dC49; Figure 13). Also
the protein was truncated to delete the leucine zipper motif and the
transmembrane and cytoplasmic regions as previously described (dC91). Since
neither of these mutant proteins have the membrane anchor region , they were
secreted from the cell. Neither mutant was able to induce fusion when co-
expressed with HN (not shown). Neither mutant was able to induce fusion when
co-expressed with HN (not shown). To examine the oligomeric structure of these
mutants, cells expressing these mutant genes were radioactively labelled , and
the cell lysate or supernatents were fractionated on gradients previously
described. The protein in the resulting fractions was immunoprecipitated with a
monoclonal antibody generated against mature virion F protein. As shown in
Figure 25, both of the truncation mutant proteins sedimented on the gradient
consistant with having an oligomeric structure. No fusion protein was detected in
the monomer region. The sedimentation pattern of proteins derived from the cell
lysate and supernatant were similar and only one gradient of each mutant is
shown. The antibody immunoprecipitated nonspecific species that sediment
near the top of the gradient (Figure 25A).
If these oligomeric forms were due to an association with host protein
host proteins would be expected to co-immunoprecipitate with these molecules.
No host proteins co- immunoprecipitated in the fractions with the fusion proteins.
These results indicated that the carboxy-terminal 91 amino acids of the fusion
protein molecule do not function in the stability of this oligomeric structure.
Heteroligomer formation. Several laboratories have suggested that the F
and HN proteins must interact for membrane fusion to occur (Sergei et ai , 1993,
Hu et ai , 1992). It was possible , therefore, that the leucine zipper motif might
function in an interaction of the F and HN proteins and the leucine mutations may
disrupt this process. Therefore, an attempt was made to develop an assay that
may identify an association between the two proteins. With this tool , it would
then be possible to determine whether a correlation existed between an inability
to promote membrane fusion by the leucine mutants and an inability to associate
with the HN protein.
Initially, various pulse-chase protocols were used to co-immunoprecipitate
F and HN from cotransfected or infected cells. Using antibodies directed against
either protein and against both mature and immature molecules, no associations
were detected. It was possible that the conditions used to solubilize the cells
disrupted an association between the two proteins. To overcome this obstacle
the cell-surface molecules were cross- linked prior to immunoprecipitation.
Several homobifunctional cross- linking agents with a range of linker-lengths were
tested. Under no conditions were the attempts to appreciably co-
immunoprecipitate cross- linked F and HN proteins reproducibly successful.
DISCUSSION
A leucine zipper-type amphipathic alpha helix is found adjacent to the
transmembrane region in paramyxoviruses (Buckland , 1989) and coronaviruses
(Britton, 1991). When Buckland and coworkers replaced four of the heptadic
leucines in the measles virus fusion protein , fusion was abolished. Similarily,
fusion activity of the NDV fusion protein containing two or more leucine
substitutions in this region is abolished.
The leucine zipper motif is spatially placed well away from the presumed
site for the fusion-promotion region of the proteins. It was expected, therefore
that this region does not directly participate in membrane fusion. However
mutations of conserved leucine residues resulted in proteins whose transport and
folding was similar to that of the wild-type protein , as indicated by the ability to be
detected by conformation sensitive monoclonal antibody. The lack of fusion
activity for the double and triple leucine mutants also cannot be accounted for by
a lack of cell surface expression or precursor processing. When cells expressing
the panel of mutant proteins were examined , the faster migrating F 1 species was
detected at the surface in all cases. Thus, the leucines are not conserved for
these functions. Indeed , the helix and all subsequent residues can be deleted
causing no apparent defect in transport , cleavage or antibody reactivity,
suggesting that this region may have little role in the actual folding of the
molecule.
The prediction that a leucine zipper motif may function in oligomer
formation (Buckland and Wild , 1989) led to an examination of the oligomeric
structure of the F protein. When the wild-type F protein is sized on sucrose
gradients, the mature protein consistantly sedimented as a 190 kD species
between the aldolase (158 kD) and catalase (240 kD) molecular weight markers.
The calculated molecular weight of FO is 56 kD after signal sequence cleavage.
Glycosylation at 4 sites may add 12 kD (prior to trimming in the Golgi) resulting in
an F monomer with an estimated molecular weight of 68 kD. The sedimentation
profile would suggest that the F oligomer is a trimer. The gradients gave no
- -
indication that the mature protein exists as a 68 kD monomer, dimer (136 kD), or
tetramer (272 kD). This result is in agreement with the recent report from
Russell and coworkers (1994) that the electrophoretic migration of cross- linked
SV5, NDV and HPIV-3 fusion proteins is consistent with trimeric structures
(Russell et ai , 1994). In contrast, crosslin king studies with the Sendai F protein
(Sechoy et aI. , 1987) and sucrose gradient analysis of the respiratory syncytial
virus F protein (Collns and Mottet, 1991) suggested that the paramyxovirus F
proteins exist as a tetramer.
There may be several explanations for this discrepancy. The protein
Sechoy and coworkers used for these studies was iodinated in the presence of
H202, and it is possible the protein conformation was altered by this strong
oxidizing agent. The gradient conditions used by Collns and Mottet of pH 5.8 run
at 40 C differ significantly from the conditions used in this study (pH 7.4 and
C) and may account for the differing sedimentation results.
The exact number of monomers within the F oligomer cannot be
determined without x-ray crystallographic data. Even the oligomeric form of the
intensively studied HIV envelope glycoprotein has not been elucidated by these
methods as it has been reported to form both a trimer (Weiss et aI. , 1990) and
tetramer (Earl 1990). However, the existence of a single homogenous species of
the F protein following centriguation through sucrose gradients suggests that only
one of the several forms of F detected following SDS-PAGE are native
structures. Furthermore, the oligomeric species of the fusion protein was not
stable in 5% SDS, indicating that it is held together by noncovalent forces. Since
monomer release is dependent on SDS , it is likely that the larger structures of F
detected following electrophoresis in SDS represent aberrantly aggregated
and/or incompletely solubilzed monomers (Figures 14 and 15).
The fusion protein containing three leucine to alanine changes sedimented
on sucrose gradients in the same position as the wild type protein. This result
shows that the leucine zipper motif is not required for oligomer formation.
Furthermore, the sedimentation profile of the truncation mutants indicated that the
leucine motif and all subsequent residues are not necessary for assembly of the
Triton X-1 00 insensitive oligomeric structure. These results are comparable to
those found by Singh et al (1990) and Crise et al (1989), who found that truncation
mutants of the fusogenic influenza HA and VSV G proteins , respectively, lacking
the membrane anchor and cytoplasmic domains, could form trimers. Cellular
transport of many viral glycoproteins has been shown to be dependent on prior
oligomerization (for review see Doms et al 1993). Since the truncated F protein is
secreted as an oligomer, the portion of the NDV F protein required for
oligomerization and, therefore , cellular transport, involves regions upstream from
the leucine zipper. Additional mutational analysis wil be required to identify the
domains within the protein that are responsible for proper oligomerization.
The absence of fusogenic activity of the fusion protein with the multiple
leucine mutations may be due to an inabilty to properly interact with the NDV HN
glycoprotein. Reports from our laboratory suggested that a specific interaction
between F and HN proteins must occur to promote membrane fusion (Sergei et
, 1993). Also, a study that substituted the PIV2 HN for a HN protein from a
genetically similar virus found that fusion by the PIV2 F protein strictly required
the PIV2 HN protein (Hu 1992). The HN protein has previously been shown to
have a distinct fusion promotion function (Sergel 1993a). One way that these
proteins could associate is by the leucine-zipper motif that they both contain near
their transmembrane region. When the HN residues 96-116 , just past this
transmembrane region , are positioned on an ideal alpha-helix, a hydrophobic
face of the helix contains a Leu- lie-Leu strip on one side. The HN molecule , a
type" glycoprotein , is anchored in the membrane in the opposite orientation with
respect to the fusion protein and this orientation would fit the criteria of
dimerization originally proposed for the C/EBP leucine zipper by Landschultz et
al. (1988). Since side chains tend to angle towards the amino terminus of a helix
the authors suggested that an anti parallel arrangement is better suited for side
chain interlocking between leucine zippers than a parallel orientation. Specificity
of the interaction could be rendered by an attraction between polar side chains of
the helix (O'Shea et ai , 1992). According to this model , two transmembrane
proteins could interlock only if they were anchored in opposite orientations.
All the paramyxoviruses encode a glycoprotein with the unusual type"
topology that would conveniently fit this model of dimerization. However, efforts
to cross- link F and HN have been unreported as well as personally unsuccessful.
However, this inabiliy to crosslink the two proteins may have several
explanations. It is possible that there is an absence of basic residues in positions
appropriate for cross- linking the two proteins. This is supported by the
observation that even the disulfide- linked HN dimer is difficult to appreciably
crosslink using noncleavable agents (Nagai , 1978, and personal observations). It
may also be possible that the required association of F and HN is very transient.
However, it would be unlikely that an association via hydrophobic interactions
would be so fleeting as to be undectable. Another possibility is that an activation
of the fusion protein by HN may occur at such a low frequency that it would be
undetectable. Spruce and coworkers (1991) have reported that only a few
molecules are required for fusion pore formation , and it seems reasonable to
expect that this activity need only occur at points of cell-cell contact.
It was possible that the multiple leucine mutants altered the expression of
HN protein. To establish the co-expression of HN and the mutant fusion proteins
at the surface of the cell , the cell surface antigens were immunoprecipitated and
revealed that HN was properly expressed in all cases.
What is especially puzzling about these results is that the alanine
substitutions were extremely conservative. Chou and Fasman (1974) have
indicated that the alanine and leucine amino acids have a comparable potential
to form an alpha helix, suggesting that the hypothetical alpha helix would not be
disrupted by the alanine substitutions. The alanine residues may be less able to
participate in hydrophobic interactions, as the residues differ significantly in their
hydrophobicity (Kyte and Doolittle, 1982). Leucine residues have a long side-
chain and the two methyl groups branch out to form a Y -shaped structure. This
side chain is optimal for fillng space between helices in a knobs- into holes
fashion as is predicted for stabilizing dimer formation (Landshultz , 1988). The
alanine residue has only one methyl group, and this side chain may not be able
to interact with longer side-chains. However, this thesis work gave no indication
that these residues play any role in the oligomeric structure of the protein.
It is entirely possible that this region of the fusion protein plays an
unknown role in the biological activity of the protein. A diverse group of proteins
contain a leucine-zipper motif which do not function in oligomerization. For
instance, a family of voltage-gated K+ channels contain a conserved leucine
zipper adjacent to a proposed transmembrane region this is expected to playa
role in the transduction of charge (McCormack , 1991). The same motif in soluble
proteins also may have diverse functions. The Drosophila poly(ADP)-ribose
polymerase protein contains heptadic leucines on an alpha-helix of its auto-
modification domain that may regulate protein-protein interactions (Uchida 1993).
The apo B mRNA editing protein requires the leucine zipper motif for its editing
function (Teng, 1993), whereas the cytoplasmic zipper of HIV gp160 has been
shown to bind calmodulin (Srinivas, 1993). Lastly, the heat shock transcription
factor monomer has four leucine zipper motifs which regulate the heat-dependent
trimer formation (Rabindran 1993).
Amphipathic alpha-helices may exhibit an additional behavior. The
fusogenic and hemolytic peptide melittin has been reported to lie parallel to the
membrane surface by virtue of a hydrophobic face of an alpha-helix (Altenbach et
, 1989; Dempsey, 1990) as have portions of the apoplipoproteins and
apolipoprotein analogs (Segrest, 1992). The hydrophobic photolabeling studies
of Harter and coworkers suggested that the influenza HA fusion peptide may also
have this topology (1989). In addition , the protein components of plant storage
lipid bodies, the oleosins , are predicted to have domains with this structure and
membrane topology (Murphy et ai , 1991).
These examples of membrane interactions of amphipathic helices along
with results from this work has led to the model depicted in Figure 26. The
premise of this model is that the conserved leucines do not function in
oligomerization but the long leucine side chains interact with the hydrophobic
mileu of the membrane and would effectively increase the area of the protein
that is anchored in the membrane. The multiple zipper segments may radiate
from the oligomer in a propeller- like fashion.
Several observations support this model. Insertion of the leucine zipper
domain through the ER membrane may be incomplete due to its hydrophobic
nature and proximity to the transmembrane domain. As potential amphipathic
alpha helices have been shown to attain a helical secondary structure in the
presence of lipids with the hydrophobic face of the helices spontaneously
associating with the hydrocarbon chains of the bilayer (Segrest , 1990; DeGrado
et ai , 1993), the zipper motif may form a helical structure and associate with the
bilayer. If the conserved leucine residues in the NDV F protein are replaced with
an amino acid with short side-chains, such as alanine, the hydrophobic
interaction with the bilayer would be diminished. In such a model , the charged
residues on polar sides of the helix would interact with the polar extracellular
solvent and the polar head-groups of the membrane. It is likely that these
interactions with the polar face of the helix would not be specific , and therefore
could tolerate substitutions as was suggested with the E482K and N485K
mutants. However, Anantharamaiah and coworkers have used an 18-residue
peptide to show that positively charged residues at the hydrophobic-hydrophilic
interface of an amphipathic helix assists the helix in binding to the phospholipid
and promoting lipid hydration (1985; Epand et ai , 1989). Thus, the lysine-rich
strip (or g positions , Figure 12) may be less able to tolerate substitutions.
Mutations of these residues would address this point.
The residues between the transmembrane domains and leucine zipper
motifs of the paramyxovirus s are rich in serines and glycines , and these residues
may allow the protein to bend between the two segments. Both residues have a
high bend potential and frequently occur at B-turn regions in a polypeptide chain
(Chou and Fasman , 1977).
The induction of membrane fusion by amphipathic helices such as melittin
has been attributed to a local disruption of the bilayer (Dempsey, 1990). Thus,
the presence of the leucine zipper helices inserted into the cell membrane may
similarly perturb the membrane and induce fusion. The transmembrane domains
themselves have also been proposed to destabilize the bilayer and may
contribute to the process (Siegel 1993). During membrane fusion with a target
cell , the fusion peptide inserts obliquely into the target cell bilayer (Ishigura
1993) and is thought to disrupt target membrane. At this point, the two
membranes are tethered together by the two hydrophobic domains on the 
I. ,
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polypeptide. The leucine "propeller" may function to disrupt the host cell
monolayer in response to any conformational changes in the ectodomain of the
protein. As suggested in Chapter 3, the first heptad repeat may also associate
with membranes. Consequently, a disruption in both the infected cell and target
cell membranes should assist in the fusion process (Helm , 1989). Alternatively,
the helices may nucleate a channel allowing lipid mixing between the two
membranes.
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Figure 11. Allgnment of the leucine zipper motif of seven paramyxovirus fusion
proteins. Sequences were adopted from Morrison and Portner (1991). NDV F
protein residues 462-502 were manually aligned with those of SV5 (Simian virus
5), MuV (mumps virus), RV (Rinderpest virus), MV (measles virus), SV (Sendai
virus), and RSV (respiratory syncytial virus). The beginning of the potential
membrane spanning region of the NDV strain is the last alanine residue shown
(#500). The glycosylation consensus site is underlined.
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Figure 12. Helical wheel representation of the amphipathic structure of residues
467-515 of the NDV fusion protein. The most amino terminal residue is placed at
position number one of the idealized helix. All subsequent residues are rotated
by 100 from this position. The distribution of charged side-chains is indicated.
Potential helix-breaking glycine residues are indicated by the lower case g.
Position of substitutions are marked by arrow. The glycosylated asparagine
residue is underlined.
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Figure 13. Description of mutations in the leucine repeat region. The amino acid
sequence for the wild-type protein , residues 467-504 are shown in A. The
nomenclature used for individual mutants is shown at left. Conserved residues 
leucine zipper are indicated by vertical boxes. Substitutions are indicated below
the wild-type sequence. Panel B shows structurally significant domains in the F 
and F2 subunits of the mature protein and the relative position of the termination
sites used to produce the dC49 and dC91 mutants. FP , fusion peptide; AAH
amphipathic alpha helix; LZ, leucine zipper motif; TM , transmembrane domain; * ,
potential glycosylation sites. S-S represents a proposed disulfide linkage
although the actual cysteine residues involved are unknown. Generation of the
mutants is described under Materials and Methods.
'", ",'"",.
o'p," 
.." . - 
!I. 
.-.. '...
Fnr -
":..
Figure 14. Western blot analysis of mutant fusion proteins. Cells transfected
with wild type and mutant DNAs were lysed at 48 hours post-transfection and the
post-nuclear extracts were mixed with sample buffer and incubated at 85 for two
minutes and electrophoresed under nonreducing conditions on a 10% gel and
subjected to western blot analysis as described in Materials and Methods. Blots
were probed with an antibody raised against the C-terminus of the NDV fusion
protein (Wang et ai , 1992). Lane 1, pSVL; lane 2, pSVL-F; lane 3, pSVL-L3A;
lane 4, pSVL L4A; Lane 5, pSVL-L5A; lane 6, pSVL-L34A; lane 7 , pSVL-L35A;
lane 8, pSVL-L45A; lane 9, pSVL-L345A. Fnr indicates the monomeric
nonreduced, form of the fusion protein.
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Figure 15. Metabolic labeling of F proteins expressed in Cos cells. At 48 hours
post-transfection, transfected cells were radioactively labeled for two hours with
(35S)methionine and proteins in the post-nuclear extract were
immunoprecipitated with an anti-F monoclonal antibody (Fu1 a). The precipitated
proteins were mixed with sample buffer and heated at 85 for two minutes prior to
loading gel. Lane 1 , pSVL; lane 2 , pSVL-F; lane 3, pSVL-L3A; lane 4 , pSVL-L4A;
lane 5, pSVL-L5A; lane 6, pSVL-L34A; lane 7 , pSVL-L35A; lane 8, pSVL-L45A;
lane 9, pSVL-L345A. Fnr, nonreduced, monomeric form of the protein.
7 8 10 11 12 13
,,- , .... . - ..... . '... . : ,." - .. 
Fnr
10 11 12 13
t .... 
.. '.. 
.W. 
- '. ... , ' ,
t j
."'4
..'
.. FO
" '
",c. 
Figure 16. Cell surface expression and precursor processing of mutant proteins.
At 40 hours post-transfection , the cells were radioactively labelled for 2 hours and
chased with nonradioactive media for 4 hours. The cells were washed in ice-cold
PBS and treated with anti-NDV polyclonal antibody as described in Materials and
Methods. Immune complexes containing cell surface proteins were precipitated
and electrophoresed in the absence of reducing agent (Panel A) or under reducing
conditions (Panel B). (A) Lane 1 , pSVL; lane 3, pSVL-F; lane 4 , pSVL-L3A; lane
5, pSVL-L4A; lane 6, pSVL-L5A; lane 7 , pSVL-L34A; lane 8, pSVL-L35A; lane 9,
pSVL-L45A; lane 10, pSVL-L345A; lane 11 , pSVL-S473A; lane 12 , pSVL-E482K;
lane 13 pSVL-N485K. Lane 2 controls for antibody released during cell lysis and is
from a lysate of unlabeled F-expressing cells incubated with anti-NDV antibody,
mixed with an extract from labeled , F-expressing cells not treated with antibody.
Fnr, nonreduced form; FO, precursor form; F1, F1 subunit.
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Figure 17. Quantitation of fusion activity of wild-type glycoproteins. The number
of nuclei in 40 fusion areas was determined at 24 , 48 and 72 hour post-
transfection to indicate the average size of syncytia at each time point. The value
obtained from pSVL alone has been subtracted. The standard deviation (vertical
lines) and average values from three separate experiments (column) are shown.
The values from transfections with pSVL- , pSVL- , and pSVL-F and pSVL-
are shown.
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Figure 18. Quantitation of fusion acitivy with single leucine-to-alanine mutations.
The standard deviation and average values were obtained as described in the
legend to Figure 17 and in Materials and Methods. Values shown were obtained
from co-transfections of pSVL-F and pSVL- , pSVL-L3A and pSVL- , pSVL-
L4A and pSVL-HN, pSVL-L4A and pSVL- , and pSVL-L5A and pSVL-HN.
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Figure 19. Quantitation of fusion activity with multiple leucine substitutions. The
values and standard deviation were obtained as described in the legend to Figure
17 and under Materials and Methods. Values shown were obtained from co-
transfections of pSVL-F and pSVL- , pSVL-L34A and pSVL- , pSVL-L35A
and pSVL- , pSVL-L45A and pSVL- , pSVL-L345A and pSVL-HN.
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Figure 20. Western analysis of fusion proteins with nonconservative substitutions
within the zipper motif. Proteins in transfected cells were prepared
electrophoresed in the absence of reducing agent , and detected as indicated in
legend to Figure 14. Lane 1 , pSVL; lane 2 , pSVL-F; lane 3, pSVL-S473A; lane 4
. pSVL-E482K; lane 5, pSVL-N485K. Fnr, nonreduced, monomeric form.
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Figure 21. Quantitation of fusion activity with nonconservative substitutions.
The values and standard deviations were obtained as described in the legend to
Figure 17 and under Materials and Methods. Values shown were obtained from
co-transfections of pSVL-F and pSVL- , pSVL-S473A and pSVL- , pSVL-
E482K and pSVL- , and pSVL-N485K and pSVL-HN.
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Figure 22. Sucrose gradient analysis of wild-type and L345A fusion proteins. 
48 hours post-transfection , cells were lysed and the extracts layered on a 10-
25% sucrose gradient as described under Materials and Methods. Proteins in
each fractions were TCA precipitated , solubilized and electrophoresed as
described under Materials and Methods. Blots were probed with an antibody
generated against the C-terminus of F. Panel A , fractionation of wild-type cell
lysate. Panel B , fractionation of cells expressing the L345A mutant. Lanes 1 , M
A V virion proteins; Lanes 2 , one-third of total solubilized pellet; lanes 3-20,
fractions 1-15, 17, 19, and 21, respectively. Positions expected for an ideal
monomer, dimer, trimer and tetramer are indicated above lanes 18, 14 , 10, and
, respectively.
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Figure 23. Helical wheel representation of the amphipathic helical structure of
residues 123-192 of the NDV fusion protein. The most amino terminal residue is
placed at position number one of the idealized helix and is the sixth residue of the
fusion peptide. All subsequent residues are rotated by 100 from this postion.
The distribution of charged side-chains is indicated. Potential helix-breaking
glycine residues are indicated by the lower case g. Position of mutational
substitutions are marked by an arrow.
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Figure 24. Sucrose gradient analysis of mutants with disruption of two potential
alpha helices. At 48 hours post-transfection , cells expressing the A 140K/L345A
or K155UL345A proteins were lysed and the post-nuclear extracts were
centrifuged through a 10-25% sucrose gradient and the resulting fractions were
electrophoresed in the presence of reducing agent as described under Materials
and Methods. Blots were probed with an antibody generated against the C-
terminus of F. Panel A , fractionation of A140K/L345A cell lysate. Panel B
fractionation of K155UL345A cell lysate. Lanes 1 , M , A V virion proteins , lanes 2
one-third of total solubilized pellet, lanes 3-20, fractions 1-15, 19 and 21.
Positions expected of an ideal monomer , dimer, trimer and tetramer are indicated
above lanes 18, 10, and 5, respectively.
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Figure 25. Sucrose gradient analysis of truncated mutants. Panel A , at 48 hours
post-transfection , cells expressing the dC49 mutant protein were radioactively
labelled for 2 hr and chased with nonradioactive methionine for 6 hours. The
culture media was removed, layered over a gradient, and fractionated as
described under Materials and Methods. The resulting fractions were
immunoprecipitated with a monoclonal antibody directed against mature F
protein. Lane 1 , total extract from A V infected and radiolabeled cells; lane 2
immunoprecipitate from solubilized pellet; lanes 3-20, immunoprecipitated
proteins in fractions 1-5, 17 19, and 21 , respectively. Panel B , at 48 hours post
transfection , cells expressing the dC91 mutant were radioactively labelled for 2
hours. The cells were lysed and the post-nuclear fraction was layered over a
gradient as described previously. The resulting fractions were
immunoprecipitated as in Panel A. Lanes are identical as those described for
Panel A. Relative positions expected for an ideal monomer, dimer, trimer and
tetramer are indicated above each figure.
Figure 26. Schematic of hypothetical model depicting the membrane topology of
the leucine zipper motif. (A) represents the oligomeric structure of the mature
fusion protein along with the exposed fusion peptides of the F 1 subunits. (B)
represents the bilayer of the infected cell membrane. (C) represents the
amphipathic helix of the conserved leucines. The heptadic leucine and
isoleucine residues are shown and are expected to be in contact with the
hydrophobic portion of the monolayer. (D) and (E) represent the transmembrane
domain and cytoplasmic tail , respectively. Only two subunits of the proposed
oligomer are shown.
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CHAPTER V
THE ROLE OF THE AMINO TERMINUS OF THE F1 SUBUNIT
OF THE NDV FUSION PROTEIN
INTRODUCTION
There are a variety of strains of the Newcastle disease virus which differ widely
virulence for its avian host. Infection with a virulent strain can result in 100%
mortality in an avian population , whereas avirulent strains result in very low mortaliy
rates. Originally, the virulence of an NDV strain was determined by its ability to kil
chick embryos following allantoic inoculation. By definition , virulent strains will kil
100% of embryos within 48 hours (Granoff , 1964).
The strain-specific difference in virulence is determined primarily by a structural
variation of the viral fusion glycoprotein. The fusion protein mediates fusion of the viral
envelope with the host cell plasma membrane, thereby enabling the penetration 
viral genome into the cytoplasm. The fusion protein is initially synthesized as a
biologically inactive precursor termed FO. During transport through the cell , the
precursor may be cleaved by a host endoprotease. The resulting two polypeptides, F 
and F2, remain disulfide- linked through cysteine residues. This cleavage, which is
required for the fusion activity, positions the hydrophobic fusion peptide at the new
amino terminus of F1. In virulent strains, cleavage of the precursor occurs in many cell
types after transport through the Golgi apparatus and results in a systemic infection. 
avirulent strains , cleavage of the fusion protein only occurs in the presence of a few
cell types (such as those of the respiratory tract), which secrete a virus activating
protease , such as V AP , resulting in a localized infection (Ogasawara et ai , 1992). In
101
he absence of cleavage, the F protein cannot promote membrane fusion.
: onsequently, the cleavabilty of the F protein determines the virulence of the virus
nd the availabiliy of an appropriate protease determines the host range and tissue
The difference in cleavability of the fusion proteins derived from different strains
'. of NDV has been attributed to an amino acid sequence difference at the cleavage site
H#;;(Glickman et ai , 1988; Toyoda et ai , 1989). A comparison of the sequence around the
;:;If;:.
cleavage site of the F protein from a number of different strains of NDV is shown in
' :
Figure 27 A. The fusion proteins from the readily cleaved virulent strains contain two
pairs of basic amino acid residues at the cleavage site and are recognized by an
intracellular protease , furin , commonly present in eukaryotic cells (Barr, 1990). The
fusion proteins from avirulent strains have a pair of single basic residues at the
cleavage site. In cell culture, these avirulent strains require the addition of a protease
such as trypsin to cleave the monobasic site , allowing plaque formation (Gotoh et ai
1990).
Figure 27B shows the sequence around the cleavage site of many different
paramyxoviruses. The cleavage site sequences are shown along with the beginning
of the fusion sequence at the amino terminus of F1. The fusion sequence is well
conserved across the family and begins with a phenylalanine in virtually all
paramyxoviruses. The Phe- Gly motif is frequently found in the fusion protein in
other families of enveloped viruses (Figure 27C). A striking exception to this motif is
the avirulent strains of NDV, which all have a leucine at the initial position.
The requirement for a specific residue adjacent to the cleavage site has not
been examined. The question this work addressed was what role the leucine residue
p1ays in this avirulent phenotype. The results indicated that this leucine residue
influences cleavage and suggested that a single nucleotide change can abolish the
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virulence of NDV. These results may have implications with respect to the origination
of avirulent strains of NDV.
RESULTS
To evaluate the requirement of the conserved phenylalanine at the cleavage
site of the F protein of virulent strains , residue 117 was changed to a leucine to mimic
the residue in the avirulent fusion proteins. A single nucleotide change created this
F117L mutant. The phenylalanine was also changed to a glycine to create the F117G
mutant. Both of these mutations keep the upstream cleavage site of this virulent A 
strain unaltered. Following cleavage of the precursor, residue 117 of the nascent
protein becomes the amino terminus of the F1 molecule.
To examine the properties of these mutants , the DNAs were subcloned into
pSVL , an SV40-based expression vector. These clones were expressed in Cos 7
cells using a DEAE-dextran transfection protocol. By immunofluorescence , both
mutants , as well as the wild-type protein , are found expressed at the cell surface
(Morrison et ai , 1993).
To investigate the abilty of these two mutants to promote fusion , they were
tested in a fusion assay developed in this lab. In this assay, the F cDNAs are co-
transfected with HN cDNA. At 24 48, and 72 hours post-transfection , the average
number of nuclei per synctyia were determined. When compared to wild type , the
substitution of phenylalanine with glycine maintained the ability of the protein to
induce fusion. This result suggested that the conserved phenylalanine at the amino
terminus of F1 is not required for the fusion activity of these virulent viruses. However
substitution of the phenylalanine with leucine virtually eliminated the fusion activity of
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. the protein (Morrison et ai , 1993).
The absence of fusion activity with the leucine mutant could be explained if this
fusion protein is not cleaved. To determine whether or not this mutant becomes
cleaved in the cell , proteins present in Iysates from transfected cells were examined by
western blot analysis. The blot was probed with a polyclonal antibody directed against
the C-terminus of F (obtained from Mark Peeples; Wang et ai , 1992). When the mature
fusion protein is treated with reducing agents , the disulfide linked polypeptides
separate. Under these conditions, only F 1 , the larger of the two subunits, is detected
as well as the uncleaved precursor. As shown in Figure 28, both the wild type and
glycine mutant proteins are readily cleaved and the cleaved forms migrate with the
viral F1 molecule. Under these conditions , the leucine mutant shows no cleavage.
This result indicated that the cellular protease is unable to cleave the arginine-leucine
bond at the processing site.
The absence of cleavage of the F117L mutant could account for its lack of
fusion activity. Therefore , an attempt was made to activate the fusion activity of this
leucine mutant by cleavage with trypsin. In this assay, trypsin should cleave any
susceptible protein expressed on the cell surface. When trypsin was added to an agar
overlay over cotransfected cells, the leucine mutant was able to stimulate the formation
of syncytia (Morrison et ai , 1993). This result indicated that the presence of a leucine
residue at the amino terminus of the F 1 portion of the fusion protein is not detrimental
to the fusion activity of this protein. Once the precursor is cleaved , the F1 protein
beginning with a leucine , glycine, or phenylalanine is functional in mediating fusion.
DISCUSSION
The amino terminus of F1 begins with a Phe- Gly in all virulent NDV fusion
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Iycoproteins in the family of paramyxovirus and this motif is found in the glycoproteins
from other viral families (Gallaher, 1987). This conserved region is at the amino
terminus of the hydrophobic fusion peptide of NDV and was expected to be crucial for
the biological activity of the protein. Mutational analysis of the first amino acid in this
motif revealed that this position can accept mutations and stil have syncytium-
c:inducing activity.
, "
An unexpected result from this work is that this initial residue of F1 does not
affect fusion but affects the precursor processing site. There have been several
';f"
:;t;
; reports that viral glycoprotein precursors are processed by furin , a member of the
: .
J: subtilsin family of proteases , that cleaves after the RxR/KR sequence of amino acids
, ,
(Steineke-Grober et ai , 1992; Gotoh et ai , 1992). This ubiquitous enzyme cleaves
proteins as they are transported through the constituitive secretory pathway of the
Golgi apparatus (Steiner et ai , 1992). There have been no reported restrictions about
the amino acid immediately following the furin processing site. The work presented
here indicates that the amino acid at the C-terminal side of the cleavage site can alter
the ability of the cell-associated protease to process a precursor. Although a glycine
or phenylalinine residue in this position allows processing, it is possible that the
leucine residue may cause a change in conformation that makes the cleavage site
inaccessible. Furthermore, these results show that the cleavage of FO can be
eliminated by a single nucleotide change which converts the phenylalanine (TTT) to a
leucine (CTT). In otherwords, this single change converts the virulent form of the
fusion protein to an avirulent form.
These results further suggest that avirulent strains may have evolved from
virulent strains by a single nucleotide mutation. When viral stocks are passaged in
chick embryos, the fusion protein in avirulent viruses is cleaved and viral growth is as
vigorous as that of the virulent viruses (Granoff , 1964). This indicates that the cell
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types in the embryo produce a protease that can recognize the RxxR-L processing site
of the avirulent strains. Gotoh and coworkers have isolated from chick embryos a
calcium-dependent serine protease designated V AP , that is highly homologous to the
activated form of the blood clotting factor X (FXa) (Gotoh et ai , 1990). FX is a member
the prothrombin family and circulates as an inactive precursor until the blood clotting
cascade takes place. The activated form of this enzyme is secreted into the amniotic
allantoic fluids and may be activated at sites of tissue damage (Ogasawara et ai
1992). This protease cleaves after the arginine residue at the Glu-Gly-Arg processing
site in prothrombin (EGR-T/I) and in monobasic processing sites of glycoprotein
, precursors such as found in the avirulent NDV strains. The specificity of this protease
suggests that the V AP/FXa protease is a determinant of viral tropism of the avirulent
The existence of this type of protease allows for the replication and for the
natural maintenance of the avirulent strains. This protease may also allow for the
origination of avirulent isolates. In the event that a virulent viral F protein undergoes a
spontaneous phenylalanine- leucine substitution , the altered protein can no longer be
activated by the furin protease. For this mutation to become established , the protein
must be cleaved at some point to allow viral infection and subsequent replication. 
the presence of V AP/FXa, the mutant can be cleaved and may then subsequently
evolve to be more efficiently recognized by this enzyme. In the presence of this
enzyme , the pair of dibasic residues are no longer required and further evolution may
result in a loss of the second basic residue and create the sequence found at the
cleavage site of the avirulent strains.
For the virulent strains to arise from avirulent, they would have to be in an
environment which selects for the RXRR-F motif. Of the known proteases that cleave at
monobasic sites, only FXa appears to cleave an arginine-leucine bond , while several
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proteases wil cleave if a glycine, alanine or serine are on the C-terminal side of the
. site (Devi, 1991). As the Sendai virus F protein having an XXXR-F site is cleaved in
the same embryonic fluids that the avirulent NDV strains are cleaved , it is likely that the
- .
VAP/FXa protease also cleaves a monobasic arginine-phenylalanine cleavage site
(Ogasawara et ai , 1992). Tryptase Clara is a clacium independent, serine protease,
that is found in rat lung and will also process the XXXR- , as well as the KXXR-
cleavage sites (Tashiro et ai , 1992). The results presented here indicated that furin
does not recognize the dibasic cleavage site if a leucine is at the C-terminal side of the
, cleavage site. Neither does this ubiquitous enzyme efficiently recognize a single
dibasic site (XXKR) nor the RXXR site with two single basic residues (Creemers et ai
1993). Therefore , two amino acid substitutions would have to occur for the virulent
phenotype , that recognized by furin , to evolve from an avirulent strain. If a single
amino acid change from RXXR-L (avirulent site) to either RXXR-F or RXKR-L occurred,
the isolate would not be activated by furin and still need to be propagated in the
presence of the V AP/FXa , or possibly the tryptase Clara , protease. In addition , a
minimum of three point mutations must occur to produce the virulent (RXRR-F) motif
from the avirulent (RXXR-L). The codon for the glycine in the avirulent RXGR-
sequence would have to change from GGA (for glycine) to AAA (for lysine) and would
require two base changes to code for the amino acid substitution. In addition , a third
base change , and second amino acid substitution would be required to create the
virulent RXKR-F cleavage site from the avirulent RXXR-L site. Viral replication in the
presence of the V AP/FXa protease would be under no selective pressure to evolve
either of these genotypes. Therefore, virulent fusion proteins would be unlikely to
evolve from avirulent strains.
A recent report describes a substitution of the phenylalanine at the amino
terminus of the F 1 with a leucine in the SV5 F glycoprotein that had no effect on fusion
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activity or cleavage (Horvath and Lamb , 1992). The cleavage site of the SV5 fusion
protein is RRRRR-F. As the SV5 protein has arginines in the -2 and -3 positions, unlike
the NDV F which has glycine and lysine residues in these respective positions, it is
possible that the SV5 fusion protein is cleaved by an enzyme other than the one that
cleaves the NDV F protein. The existence of subtilisn-related enzymes with slightly
different specificities has been suggested by Kawahara et al (1992), who found a
lymphoid cell line which would readily cleave the fusion protein of SV5 and PIV3 but
not virulent NDV.
With the widespread use by the U. S. poultry industry of live virus vaccines
involving the avirulent NDV strains such as B1 , the possible emergence of more
pathogenic strains from vaccine strains of low virulence is a concern. However, these
vaccines have been used for over three decades and this event has not been
documented , suggests that there is not a strong selection pressure for virulence. This
pattern lends support to the arguments presented here regarding the evolutionary
restrictions placed on the cleavage-activation site of this protein. However, further
studies will be necessary to determine cleavage-site specificity and tissue distribution
of the poteases responsible for processing the fusion protein precursor.
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F 1---
Virulent Beau SGGRRQKR FIGAIIGGVALGVATAA
Texas SGGRRQKR FIGAIGGV ALGV ATAA
AusV SGGRRQKR FIGAIGGV ALGV A TAA
Miy SGGRRQKR FIGAIGSV ALGV A TAA
Hertz SGGRRQKR FIGAIGSV ALGV A TAA
Ital SGGRRQKR FIGAIGSV ALGV A TP
Avirulent 026 SGGGKQGR LlGAIIGGVALGVATA
Que SGGGKQGR LlGAIIGGVALGVATA
Ulster SGGGKQGR LlGAIIGGAALGV A TAA
B1 H SGGGRQGR LlGAIIGGV ALGV A TAA
LaSota SGGGRQGR LlGAIIGGV ALVA TP
F117G SGGRRQRR IGAIGGV ALGV A TAA
FI17L SGGRRQRR llGAIGGV ALGV A TAA
MuV RRHKR FAGIAIGIAALGV A
SV5 RRRRR FAGWIGLALGV A
NDV RRQKR FIGAIIGSVALGVATA
RRHKR FAGWLAGAALGV A
RRHKR FAGWLAGAALGVA
APQSR FFGA VIGTIALGV AT
PI3 PRTKR FFGGVIGTIALGV A
RSV KRKRR FLGFLLGVGSAIASG
HIV- FLGFLGAAGST
HIV- FLGFLA T AGSA
STL V- FLGGLA TAG SA 
Legend to Figure 27 A. Comparison of amino acid sequences (NDV residues 109-
132) among virulent and avirulent NDV isolates (Toyoda et aI. , 1989). Mutants F117G
and F117 L are shown for comparison (Morrison et aI. , 1993). The amino terminus of
F1 initiates the fusion peptide sequence and mutations are underlined. B.
Comparison of amino acid sequences of paramyxovirus fusion protein cleavage site
sequences (Morrison and Portner 1991). MuV , mumps; SV5, Simian 5; NDV
Newcastle Disease; RV , Rinderpest; MV , measles; SV , Sendai; P13, parainfluenza 3;
RSV, Respiratory Syncytial virus. C. Partial fusion peptide sequence of representative
retrovirus glycoproteins containing the FXG motif (Gallaher 1987).
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Legend to Figure 28. Western analysis of mutant fusion proteins. Proteins present 
extracts of cells transfected with various DNAs for 48 hour were electrophoresed in the
absence (Panel A) or presence (Panel B) of B-mercaptoethanol on 10%
polyacrylamide gels and subjected to western blot analysis as previously described.
Blots were probed with an antibody directed against the C-terminus of the NDV F
protein. Lanes 1 , NDV virions grown in eggs (AV); lanes 2 , pSVL-F (F), lanes 3, pSVL-
F117G (G); lanes 4 , pSVL-F117L (L); lanes 5, pSVL (v).
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CHAPTER VI
DISCUSSION
Membrane insertion. The cell-free translocation system has revealed that the
NDV fusion protein behaves like a typical type I integral membrane glycoprotein. Only
the hydrophobic amino terminal sequence of the protein is recognized by SRP and
this segment targets the precurser to the rough ER vesicle. Translocation of deletion
mutants indicated that membrane translocation is arrested by integration of the
hydrophobic domain near the C-terminus. Following insertion of the nascent
molecule, enzymes within the lumen of the ER vesicles cleave the signal sequence
from the protein and add oligosaccharides to the protein.
This translation system also produced other species of the protein. A major
species of protein was not targeted to the ER , possibly due to a limiting amount of SRP
or vesicles, and remained as full- length unprocessed molecules. In addition , a
population of fusion protein molecules were integrated in the membrane by the fusion
peptide. These molecules were glycosylated at only one site and were initially
undetected as they comigrated with the nascent, untranslocated, protein. Protease
digestion of the protein products completely digested the untranslocated protein and
revealed the additional population in which a 21 kD portion of the molecule was
translocated. In the absence of the fusion peptide , this topology was not observed.
The possibility that a partially anchored fusion protein also occurs during
cellular synthesis of the fusion protein has been suggested by several curious
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experimental results. A consistent observation 
is that the amount of the F protein
detected in NDV infected cells is unexplainably low. During replication of the virus, the
amount of viral mRNAs and their protein products are made in amounts that generally
correspond to their position in the viral genome (Peeples , 1988; Kingsbury, 1990). As
the gene order is NP- HN-L, the amount of F protein synthesized should occur in
an amount less than the M protein but in higher amounts than the HN protein.
However, following a short radioactive label of infected cells, electrophoresis of the
resulting cell extract revealed the viral proteins and indicated that the 69 kD FO protein
is synthesized in approximately the same amount or less as that of the HN protein
(Figure 5). One possible reason for this result is that a population of the fusion protein
molecules halt translocation prematurely, as occurs during the cell-free synthesis.
These underglycosylated molecules would have an expected molecular weight of -
kD and would comigrate with the NP protein and be undetectable. Efforts to
immunoprecipitate this potential F species were hampered by a potential
contamination of co- immunoprecipitated NP molecules.
The transfection studies allowed examination of the topology of the F protein in
the absence of other viral proteins. Following optimization of the transfection protocol
the Cos cells and pSVL expression vector were used to express the cDNA. When F-
expressing cells were lysed and the proteins electrophoresed under reducing
conditions, an underglycosylated species was expected to comigrate with the F 
subunit (also -60 kD) and be undetectable. When precursor cleavage was inhibited
with the F117L mutant, an underglycosylated species was not detected. This result
undeniably indicated that a partially translocated population of molecules is not
detected following cellular biosynthesis.
However, further examination is required to determine if a partially translocated
species of the fusion protein escapes detection due to aggegation or degradation.
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Following anchoring of the protein at the fusion peptide, most of the molecule would
I: remain exposed to the cytoplasm. This aberrently translocated protein may be quickly
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1979; Vidal et ai , 1989), and the unglycosylated portion of the molecule may form an
insoluble aggregate. Alternatively, the lysis conditions may cause the protein to
aggregate such as occurs with the hydrophobic prion protein on contact with nonionic
detergents (Garbizon , 1987).
Another explanation for the lack of a population anchored by the fusion peptide
is that the cell-free translocation system does not faithfully reflect the cellular synthesis
of this glycoprotein. During cell-free synthesis , translocation may pause at the fusion
peptide and allow the untranslocated portion to prematurely fold, thereby inhibiting
further translocation. The cell may either not allow translocation to pause, or it may
inhibit premature folding. Both scenarios are possible. The cytosol contains
numerous components which inhibit premature folding (reviewed in Eilers and Schatz
1988) but may be lacking in the cell-free system. For example , Chirico and coworkers
(1988) have determined that the 70 kD yeast heat shock proteins, SSA 1 and SSA2
increased the rate of post-translational translocation in the wheat germ translation
system. Also, the yeast SSS1 cytosolic gene product is required for complete
translocation of secretory preproteins (Esnault et ai , 1993). As antisera raised
against this 9 kD protein recognized a small amount of a protein in a commercial
microsomal preparation , it is likely that eukaryotic cells may have a similar component.
This small protein may be lost during isolation of the ER membranes and
supplementing the translocation system with this component may further simulate
cellular translocation. It is possible that further optimization of the reaction conditions
could also increase translocation of the molecule. For example , the driving force for
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translocation or the rate of the synthesis may be inadequate and may allow
translocation to pause. In addition , a receptor that recognizes the membrane-
, spanning segment during translocation has not been identified , and this system may
be useful in characterizing this potential component. For example , the fusion peptide
may prematurely close the ER transport channel during cell-free synthesis. Fusion
peptide mutants could test the specificity of this integration mechanism.
The experimental findings described in this work have led to several predictions
that need to be addressed. The cell-free experiments attempted to determine whether
the fusion peptide could function as a signal sequence. The lack of translocation of
the MF and FSS mutants suggested that the fusion peptide failed to target the mutant
proteins to the membrane due to an inability of SRP to recognize this domain.
However, mutational analysis of the fusion peptide sequence could further define the
amino acid requirements for a hydrophobic domain to interact with SRP and function
as a type II signal sequence. In addition , the fusion peptide has been predicted to be
on the threshold of hydrophobicity to function as a membrane anchor (Paterson
1987). This prediction could be tested by increasing the hydrophobicity of the domain.
The potential for the fusion peptide to function as a stop-translocation signal in vitro but
not during cellular synthesis also needs to be further investigated. It is likely that some
required cellular component is altered or missing in the cell-free translocation assay.
In order to identify this factor, the reaction conditions could be varied or supplemented
with cellular factors.
Role of conserved motifs. The pSVL expression system has been useful in
characterizing the transport , folding, processing, and biological activity of the wild-type
and mutant fusion proteins synthesized in vivo. The system was used to examine the
significance of single conserved residues and specific sequence motifs within the
fusion protein. When the primary sequence of the protein was compared to that of
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, other proteins within the paramyxovirus family, a leucine zipper motif was identified
immediately upstream from the transmembrane region (Buckland and Wild , 1989).
This region shows high conservation of the leucine residues against a background of
c nonconserved residues and predicted that the leucines have an important function for
the biological activity of the fusion protein. Functional assays indicated that these
multiple leucines are required for the fusogenic activity of the protein. Single leucine
substitutions and nonconservative changes between the conserved leucines had little
affect on the fusion activity. The lack of fusion activity with the multiple leucine
substitutions could not be accounted for by any obvious defect in processing, folding
or expression of the mutant fusion proteins.
The presence of a leucine zipper motif suggested a function in oligomerization
of proteins. This prediction led to an examination of the oligomeric structure of the
wild-type and mutant fusion proteins. The wild-type protein was found to sediment in
sucrose gradients as a Triton-resistant trimer. The conserved leucine motif was found
not to be required for the stability of this oligomer. In addition , removal of 91 residues
from the C-terminus of the F protein did not disrupt the oligomeric form indicating that
the leucine zipper, the transmembrane domain and cytoplasmic tail are not necessary
for oligomer formation. Also , immunoprecipitation of the truncated F protein by a
conformation-specific anti-F monoclonal antibody indicated that these domains were
not necessary for the transport or conformation of the oligomer. These results were
consistant with similar examinations of the influenza HA and VSV G fusogenic proteins
(Singh et ai , 1990; Crise et ai , 1989).
The domains of the protein responsible for the oligomeric structure of the
protein should be further elucidated. It is possible that an alpha helix immediately
downstream from the fusion peptide is responsible for this structure. Several other viral
fusogenic proteins contain a long heptad repeat within a potential alpha helix
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immediately downstream from the fusion peptide (Chambers et ai , 1990). Of these
viral fusion proteins , the structure of the influenza HA molecule is the best
. characterized due to X-ray chrystalography data (see Wiley and Skehel , 1987). A
. model proposed by Carr and Kim (1993) suggests that , following activation , this
. potential alpha helix forms a three-stranded coiled coil and increases the length of the
helix extending from the membrane , interwound with two other HA2 polypeptides as a
three-stranded coiled coil. This long helical structure appears to assist in the stabilty
of the trimer of the fusogenic form of the protein (Carr and Kim , 1993).
The NDV fusion protein shares similarities with the fusogenic influenza HA
protein. Both are type I glycoproteins which are proteolyticallY processed and exist as
disulfide- linked heterodimers. The membrane-anchored subunits retain the fusion
peptide at the newly formed amino terminus. By analogy, it seems possible that the
comparably placed helix in the NDV fusion protein may also function in trimerization.
This prediction was tested with two mutants that had alterations adjacent to , and in, the
predicted alpha helical region adjacent to the fusion peptide. Although those
substitutions did not result in detection of a monomer following centrifugation through
sucrose gradients, it is stil possible that this helix is essential in the noncovalent
oligomerization of the molecule. Neither of the mutations involved the hydrophobic
face of the helix. In addition , the characteristic 4-3 hydrophobic repeat involves over 8
turns of the helix, and it is likely that single substitutions will not completely disrupt this
potential structure. Alternatively, a protein that is unable to oligomerize , or remains in
monomeric form, may be held in the ER by host-cell proteins (Doms et ai , 1993).
Therefore , the block in cellular transport of the K155L mutant (Sergei et a11994) may
be due to faulty oligomerization.
Investigations with the available analytical tools were unable to show a
correlation of an absence of fusogenic activity of the triple leucine mutant with an
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alteration in conformation. However, multiple leucines in the zipper regions are
required for the biological activity of the protein. There were several possible
explanations for this result. The leucine motif is recognized as a structure that allows
coil-coiled oligomer formation (O'Shea et al 1988). Since this motif was not noticeably
required for the F oligomeric structure it was possible that it functioned in the required
interaction with HN. Due to an inability to detect an interaction between the wild-type
proteins, this possibility cannot be ruled out.
It appears likely that the fusogenic NDV protein has adopted the leucine motif
for an unexpected function. The subtlety of the substitutions and the requirement for
multiple leucines led to a re-evaluation of the potential function of this region and to
the proposed model for the conserved leucines to interact with the bilayer. As
previously described , there are several structural features that support this model and
in addition , it is in full agreement with the experimental results. According to the
model , single leucine to alanine substitution will not be expected to disrupt the
association with the membrane. Multiple substitutions should severely reduce the
propensity to interact with the bilayer.
The model predicts that the charge distribution on the cell surface along with the
fluidity of the bilayer will allow for the nonconservative changes on the polar sides of
the potential helix. The fusogenic ability of the E482K and N485K mutants support this
prediction. In addition , the nonpolar face of the predicted helix is adjacent to a face
rich in basic lysine residues in position g (Figure 12). This basic strip of the helix may
interact with the negatively charged phosphate groups in the bilayer and affect the
association of the helix with the membrane. This model predicts that substitutions of
the lysine residues should alter the membrane association of with the helix and may
inhibit fusion.
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The model for the function of the leucine zipper requires further
characterization. The absence of fusion with the multiple alanine substitutions was
proposed to be due to a decreased interaction with the membrane. A substitution with
another hydrophobic residue such as isoleucine should maintain the interaction while
the smaller valine residue may not. It would also be interesting to increase the
potential membrane interaction by adding additional hydrophobic residues to the
hydrophobic face of the helix. Such mutations may cause the helices to embed
deeper into the membrane. These mutations may increase the disruption of the
membrane and may increase fusion. The sequence between the transmembrane and
leucine zipper is rich in glycine and serine residues. These amino acids are often
found at B-turn regions within proteins and are predicted to allow a bend between the
two domains. Removal of these residues would test this prediction and may inhibit the
abilty of the helix to interact with the membrane.
Additional insight into the function of the two amphipathic helices of NDV may
be obtained by testing for the activities proposed for other natural amphipathic alpha
helices such as the apolipoproteins. Plasma lipoproteins are macromolecular
particles that transport lipids. They are composed of a monolayer of phospholipids,
cholesterol , and apolipoproteins surrounding a core of nonpolar lipids , cholesterol
esters and triglycerides (Ponsin , 1986). The helices of the apolipoproteins are
proposed to lie parallel to the membrane and activate the plasma lecithin:cholesterol
acyltransferase (LCA T) enzyme. This enzyme transfers fatty acids from
phosphatidylcholine to cholesterol allowing for the effux of cholesterol from
membranes (Frohlich , 1992). As plasma membranes are approximately 50%
cholesterol by weight, local activation of this enzyme by the leucine zipper helices may
alter the microenvironment of the membrane in such a way as to faciliate membrane
fusion. Alternatively, the fusion protein may have an inherent lipid transport activity.
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Demel and coworkers have determined that Sendai virions mediate
phosphatidylcholine transport and that the F protein shares some homology with a
phosphatidylcholine-specific transport protein (1987). This prediction could be tested
by the addition of transport inhibitors to the fusion assay.
Another activity found with amphipathic helices such as melittin is the
stimulation of phospholipases C (Okano et ai , 1985) and A2 (Sharma , 1993) which in
turn stimulate membrane fusion (Nieva, 1993). Curiously, Iysophosphatidylcholine
inhibits both phospholipase C- induced and Sendai virus- induced membrane fusion
(Yeagle , 1994), as wll as NDV- induced syncytia formation (Kohn , 1965), by a
mechanism which is believed to inhibit membrane destabilization (Yeagle , 1994).
These results suggests that the leucine zipper motif may potentially promote fusion by
stimulating phospholipase activity and ultimately bilayer disruption. Using
phospholipase inhibitors during fusion assays could test these predictions.
A phenomenon observed during this study is that membrane association
appears to correlate with decreased cellular expression. Expression of the multiple
leucine mutant cDNAs was more efficient than with the wild-type protein. Similarily,
, the dC91 (Figure 5) and dC49 mutants had increased expression. It is possible that
extensive membrane association hampers transport from the ER. Curiously, work in
this laboratory has indicated that mutations that decrease the hydrophobicity of the
fusion peptide, along with propensity to act as a membrane anchor, also show
significantly increased expression (Sergei et ai , 1994). This potential correlation
deserves characterization.
Precursor cleavage. A common theme among many, though not all , fusogenic
proteins is the requirement for precursor cleavage (White , 1990). This cleavage often
occurs following a dibasic or monobasic processing site and is dependent on specific
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cell-derived proteases (Barr, 1991). Virions with uncleaved fusogenic proteins are
unable to infect a target cell. A leucine on the C-terminal side of the NDV F processing
site blocks cleavage by the Cos cell protease and , in effect , results in the avirulent
phenotype. Trypsin digestion of the cell surface leucine mutant indicated that the
leucine substitution does not affect cleavage by this enzyme or the subsequent fusion
event. Furthermore , a glycine at this position allowed recognition by the cell
associated protease and allowed syncytium formation. Thus , the phenylalanine
residue at the amino terminus of F1 is not conserved for the fusogenic activity of the
protein.
The cellular protease in Cos cells does not recognize the RXXR-L site of the
avirulent strains such as B1 (unpublished observation). However, propagation in
fertilized eggs or avian respiratory tract cells produces the cleaved F protein of
avirulent strains (Ogasaware et al 1992). Thus , there are at least two different natural
proteases that exist and separately process either the virulent or avirulent fusion
proteins. It is likely that more cell-type specific proteases will be identified that cleave
viral fusion proteins. For instance , the LCMV GP precursor contains a cleavage site
RR-L that is cleaved in BHK cells (Southern et ai , 1991). However, BHK cells do not
cleave an NDV fusion protein with an RXRR-L cleavage site , although MDBK cells wil
process this site (Pritzer et ai , 1990).
Similarily, the virulence of avian influenza A viruses depends on the cleavabilty
of the fusogenic HA precursor. All avian avirulent HA precursors contain only a single
basic amino acid at the cleavage site (Donis et ai , 1989) and cause a mild or
inapparent disease. The first residue following the cleavage site is a conserved
glycine. However, a glycine to alanine substitution suggested that the glycine is not
conserved for cleavability but because it promotes the fusion activity (Walker, 1993).
Kawaoka and Webster have proposed that a virulent influenza A virus arose from the
120
repeated replication of an avirulent virus in chickens (1985). Although a similar
increase in virulence of the nonpathogenic strains of NDV is possible , such an
occurance has yet to be documented. A thorough mutational examination of the
cleavage site recognized by purified proteases may reveal additional information as to
the evolutionary pressures placed on the virulent and avirulent NDV strains.
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